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ABSTRACT 
Vasopressin (VP) is an antidiuretic hormone that is synthesized and released by osmosensitive 
magnocellular neurosecretory cells (MNCs) to regulate water homeostasis in the body. The rate 
and firing pattern of MNCs determines the amount of VP release, which is elevated during 
physiological stress particularly dehydration. During acute osmotic changes the MNCs shrink 
and swell due to hypertonic and hypotonic stimuli, respectively. In contrast to hippocampal 
neurons, which display regulatory volume increases (RVI) and regulatory volume decreases 
(RVD) in response to hypertonic and hypotonic stimuli, MNCs do not have compensatory 
mechanisms. The MNCs undergo hypertrophy as a part of their physiological structural and 
functional plasticity during chronic dehydration. These changes are thought to be important 
during long term osmotic changes for the sustained and high level releases of hormone. 
However, the mechanism of hypertrophy is still unclear and it is difficult to address this issue in 
vivo. We therefore undertook studies on acutely isolated MNCs to test hypertrophy in MNCs. 
We observed that acutely isolated MNCs treated with hyperosmolar solution (325 mOsmol kg
-1
) 
for 150 minutes in vitro showed hypertrophy (a 9% increase in CSA) and recovered their original 
size when returned to isotonic solution (295 mOsmol kg
-1
) for another 60 minutes. Whole cell 
patch clamp experiments showed a 34% increase in cell membrane capacitance following 
treatment with hypertonic solution for 90-150 minutes. The osmotically-evoked hypertrophic 
response was blocked by using a TAT (human immunodeficiency virus transactivator of 
transcription) peptide (TAT-NSF700) that prevents SNARE-mediated exocytotic fusion by 
blocking the function of NSF (N-ethylmaleimide-sensitive factor).  The hypertrophic response 
did not appear to be altered by a scrambled version of the peptide, showing that osmotically-
evoked hypertrophy depends on SNARE-mediated exocytotic fusion. The VP and OT-MNCs 
exposed to hyperosmolar solution for two hours showed increased immunofluorescence for L-
type Ca²⁺ channels (both Cav1.2 and Cav1.3). Our data suggest that the osmotically-evoked 
hypertrophy is associated with an increase in the total membrane surface area due to the 
exocytotic fusion of intracellular granules with the plasma membrane and with increased 
expression of L-type Ca
2+
 channels. This study will be helpful in understanding of the adaptation 
that MNCs undergo during long term dehydration and pathological conditions that lead to 
increased plasma osmolality.  
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CHAPTER 1  
INTRODUCTION 
 
1.1 Osmoregulation and extracellular fluid (ECF) 
Body fluid is divided into two compartments, extracellular fluid (ECF) and intracellular fluid 
(ICF) (Guyton & Hall, 1996; Cecil et al., 2008). The ECF, whose main cations and anions are  
Na
+ 
and Cl
-  
respectively (Guyton & Hall, 1996), is located outside the cell and divided into sub-
compartments blood plasma, interstitial fluid and transcellular fluid while the ICF is found in 
cytoplasm (Nanovic, 2005) and has K
+
 as its main cation (Boron & Boulpaep, 2009). ECF and 
ICF are separated by a selectively permeable membrane called the plasma membrane that is 
freely permeable to water (Guyton & Hall, 1996). All mammals maintain the osmolality of the 
ECF, which is the measure of all the osmolytes or solutes (ions, proteins etc) in solution 
expressed in moles per kilogram of the solvent (units for osmolality is mOsmol kg
-1
). Osmolality 
is similar to osmolarity which is the measure of total moles of solutes per litre of the solution 
(Guyton & Hall, 1996; Bourque, 2008). Changes in extracellular osmolality make water flow in 
and out across the plasma membrane through osmosis in the form of passive diffusion i.e. water 
moves from the area of higher concentration to the area of lower concentration through the 
plasma membrane to balance extracellular and intracellular or cytoplasmic osmolality (Alberts et 
al., 1994; Russell et al., 2008). This happens because where the osmolytes are present in lower 
concentration (either inside or outside of membrane), water concentration is higher and this 
drives water to move to the other area (Strange, 1994; Boron & Boulpaep, 2009). Mammals 
share a common set point of osmolality of about 300 mOsmol kg
-1 
(Bourque, 2008). Osmotic 
pressure is created by the difference of osmolalities across the membrane. The set point of 
osmotic pressure is maintained at a stable point by the regulation of both water and sodium 
balance in both compartments (Guyton & Hall, 1996; Bourque & Oliet, 1997). A rise in plasma 
osmolality is termed as hyperosmolality and a decrease as hypo-osmolality. Changes in the 
concentrations of both water (which occurs through water intake, evaporation and diuresis) and 
sodium (which occurs through Na
+ 
intake and excretion) cause fluctuations in osmolality. Water 
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deprivation or salt intake can cause hyperosmolality, which stimulates the thirst sensation and 
also leads to antidiuretic hormone release to enhance water reabsorption in kidneys. ECF hypo-
osmolality suppresses the release of antidiuretic hormone and enhances diuresis (an increase in 
the flow of urine by the kidney) (Bourque, 2008).  
Cell volume changes are significant not only in brain but in all body organs. The expansion of 
brain cells is limited by our rigid skull and due to their fragility, they can not afford much 
osmotically-evoked cell volume changes compared to other organs. In extreme osmotic 
conditions these volume changes can be lethal (Bourque et al., 1994; Ordaz et al., 2004). The 
hypo-osmotic changes of ECF can cause swelling of brain that leads to ischemia, infarct, 
excitotoxicity and neuronal death (Ordaz et al., 2004). When cells are exposed to hypertonic 
solution (a solution having more solutes and less water), the water will tend to come out of the 
cells to equilibrate and cells shrink in size. On the contrary if cells are placed in hypotonic 
solution (a solution having less solutes and more water), the cells will swell due to water 
travelling inside of the cell (Alberts et al., 1994). This osmotically-induced swelling and 
shrinking as a result of water transport through water channels on the plasma membrane is 
regulated physiologically by regulatory volume increase (RVI) and regulatory volume decrease 
(RVD), which are compensatory mechanisms to maintain adequate cell volume (Lang et al., 
1998; Lang, 2007). These mechanisms regulate the internal osmolality by ion transport across 
the plasma membrane, leading to influx and efflux of various osmolytes as well as metabolites 
following volume changes (Lang et al., 1998).  
1.1.1 Central osmoreceptors  
All mammalian tissues experience changes in individual cell volume and their metabolic 
functions due to changes in ECF osmolality (Strange, 1994). The systemic infusion of NaCl 
triggered the thirst sensation in dogs, which gave an idea of cellular dehydration and volume 
reduction due to water efflux as a result of hyperosmolality or salt intake (Gilman, 1937). In 
1947, Verney confirmed Gilman’s findings and further suggested that cells that are specially 
sensitized to osmotic changes are located in the brain. When different blood vessels perfusing 
anterior hypothalamic region of dogs’ brains were infused with hyperosmolar solution, it 
triggered antidiuresis by the release of antidiuretic hormone (Verney, 1947).  These specialized 
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sensory cells were thought to be neurons located in the anterior region of hypothalamus (Jewell 
& Verney, 1957). As reviewed by Bourque & Oliet in 1997, the hypothalamus possesses 
osmoreceptor neurons from which the central pathway for osmoregulation originates. The 
supraoptic and paraventricular nuclei of hypothalamus and the area between these two nuclei 
contain somata of primary osmoreceptors. These cells send their projections through the median 
eminence to the neurohypophysis (Poulain and Wakerley, 1982). Moreover, there are other 
important structures in the central nervous system controlling osmoregulation that are associated 
with the lamina terminalis. They are located near the anterior part of the hypothalamus and 
include the subfornical organ (SFO), the median preoptic nucleus (MnPO) and the organum 
vasculosum lamina terminalis (OVLT) (Bourque et al., 1994; Bourque & Oliet, 1997). Peripheral 
osmoreceptors also play an important part in body fluid homeostasis (Bourque et al., 1994). 
Peripheral osmoreceptors are found in the upper regions of the alimentary tract, blood vessels 
innervating intestines, the oropharyngeal cavity, the hepatic portal vein, the liver, the 
gastrointestinal tract and the splanchnic mesentery, but their cellular and molecular anatomy is 
still unknown (Bourque, 2008).  
1.1.2 The magnocellular neurosecretory cells (MNCs)  
The primary osmoreceptors are known as magnocellular neurosecretory cells (MNCs), which are 
large neuroendocrine cells found in the supraoptic and paraventricular nuclei (SON & PVN) of 
the hypothalamus and also the area between these two nuclei (Bargmann & Scharrer, 1951; 
Bourque & Oliet, 1997). The terminals of MNCs reside in the neurohypophysis while the somata 
of MNCs are located largely in the SON and PVN and each of them contain two paired parts 
which are bilaterally located and found lateral to the optic chiasm and adjacent to the third 
ventrical respectively. It was estimated using Nissl staining of rats that each of the SON paired 
parts contains 4400 to 7000 MNCs while each part of the PVN contains 1300 to 2000 MNCs 
(Swanson & Sawchenko, 1983; Armstrong et al., 1994). The SON and PVN together contain 
50% of total MNCs of hypothalamus (Bourque & Oliet, 1997; Hatton & Li, 1998). MNCs have 
one to three dendrites extending towards the ventral glial lamina in the case of the SON and the 
third ventricle for PVN (Armstrong et al., 1994). A single axon projecting from the MNC somata 
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or primary dendrite leads to the neurohypophysis for the release of hormones to the blood stream 
(Armstrong et al., 1994).  
1.1.2.1 Hormones of MNCs 
MNCs synthesize and secrete either vasopressin (VP) or oxytocin (OT), which are neuropeptide 
hormones of special importance in mammals (Swaab et al., 1975). VP plays a significant role in 
osmoregulation and acts as an antidiuretic hormone controlling water excretion by water 
reabsorption in the kidney. VP has effects not only on osmotic regulation but also on blood 
pressure by the regulation of circulating blood volume and baroreflex sensitivity (Koshimizu et 
al., 2006) and thermoregulatory cooling by preemptive renal water reabsorption (Sharif-Naeini et 
al., 2008a). OT has mostly female reproductive functions in parturition during uterine smooth 
muscle contraction and in lactation for the milk let down by contraction of myoepithelial cells of 
mammary glands. OT is not only a female reproductive hormone but also has roles in male 
reproduction for sperm transport (Studdard et al., 2002) and in osmoregulation in some species 
(including rats) by causing natriuresis (Bourque & Oliet, 1997). Both hormones are synthesized 
and released through the hypothalamo-neurohypophysial system (HNS). They are synthesized in 
the somata of MNCs and packaged into secretory granules, which are transported to the 
neurohypophysis or posterior lobe of the pituitary gland and stored in axon terminals (Theodosis 
et al., 1978; Bicknell, 1988; Fisher & Bourque, 2001). Hormone release depends on Ca²⁺ 
triggered depolarization and exocytotic fusion of granules with the plasma membrane of the 
MNC terminals. The secretory large dense core granules contain either VP or OT, their specific 
associated carrier proteins (neurophysin II and neurophysin I, respectively) and precursors 
(Brownstein et al., 1980). Immature secretory granules are synthesized in the trans-Golgi 
network (TGN) and transformed from unregulated to regulated exocytotic carriers with the help 
of the SNARE proteins VAMP4 and synaptotagmin IV (Syt IV) while undergoing maturation 
(Eaton et al., 2000).  
VP plays an important role in various types of physiological regulations through acting on three 
G-protein coupled VP receptors, V1a, V1b and V2 receptors (Ball, 2007). The reabsorption of 
water from kidney is enhanced by VP binding with V2 receptors on the principal cells in the 
collecting ducts of kidney. Seven out of a total of eleven water channels called aquaporins (AQP) 
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are found in the kidney of mammals (Ball, 2007) and three of these water channels, aquaporin-2 
(AQP2), aquaporin-3 (AQP3) and aquaporin-4 (AQP4), are important in the VP- regulated water 
reabsorption. VP translocates the AQP2 channel by binding with V2 receptors in the principal 
cells of collecting ducts of kidneys for reabsorption of water (Petersen, 2006). The AQP2 water 
channels are translocated from cellular vesicles to the apical membrane of principal cells by 
exocytotic fusion and water enters the cell through pores present on AQP2. Then water exits 
through AQP3 and AQP4 on the basolateral plasma membrane of the collecting duct principal 
cells to the ECF (Petersen, 2006; Ball, 2007).  
1.1.2.2 Electrophysiology of MNCs  
1.1.2.2.1 Rate and firing pattern of MNCs 
MNCs are capable of displaying different rates and patterns of firing with changes in the 
osmolality of the ECF (Bourque, 1998). The amount of release of hormones is determined by the 
rate and pattern of action potentials generated in the somata of MNCs (Bicknell, 1988). MNCs in 
rats exhibit resting membrane potentials of -58 mV to -68 mV and the threshold for action 
potentials ranges from -44 mV to -55mV. MNCs display three types of firing patterns (Bourque, 
1989; Bourque, 1998) and their pattern and frequency of firing regulate the release of VP 
(Bicknell, 1988). When the osmolality of the ECF is normal, both types of MNCs (VP & OT) 
fire slowly, irregularly and infrequently at a rate of 1-3 Hz. When the ECF osmolality increases 
only by 1%, cells start firing faster and can fire in a fast continuous manner with more than three 
spikes per second (Bourque & Oliet, 1997; Poulain & Wakerley, 1982).  Further increases in 
osmolality tend to cause VP-MNCs to fire in phasic bursts. VP-MNCs show periodic burst 
activity consisting of bursts of action potentials lasting for tens of seconds and having a firing 
rate of 5-15 Hz and interburst intervals or silent periods of the same length (Poulain & Wakerley, 
1982). Most OT-MNCs do not adopt phasic bursting in response to increased osmolality, but 
during lactation or parturition they do fire rapidly with bursts of 30-50Hz, lasting for 2-4 seconds 
and recurring every 3-15 minutes (Brown & Moos, 1997). The increase in firing rate for the 
increased hormone release during conditions brought by osmotic changes is also triggered by 
continuous excitatory drive from other osmosensitive cells in the OVLT and this is required for 
the sustained phasic bursts (Richard & Bourque, 1995; Brown & Bourque, 2004). It has been 
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observed from electrophysiological recordings that after dehydration of 6 hours or more, phasic 
firing was displayed by 84-100% of VP-MNCs while only 4% OT-MNCs showed phasic firing 
even after 24 hours of dehydration (Poulain et al., 1977; Wakerley et al., 1978). Other 
neuroendocrine modulators like VP & OT are released in an autocrine fashion from 
somatodendritic regions (Ludwig & Pittman, 2003) along with peptides such as apelin (De Mota 
et al., 2004) and dynorphin (Brown & Bourque, 2004. 
 MNCs fire action potentials in different firing patterns and rates as a result of intrinsic and 
extrinsic factors (synaptic inputs). The intrinsic factors include osmosensitive channels (stretch 
inactivated cation channels; SICs) and activity dependent currents e.g. depolarizing 
afterpotentials (DAPs) (Oliet & Bourque, 1993a; Oliet & Bourque, 1993b). The action potentials 
propagate to the terminals, depolarize the membrane and activate voltage-gated Ca
2+
 channels 
(VGCCs), and ultimately release hormone into the blood circulation from the neurohypophysis 
(Bicknell, 1988; Fisher & Bourque, 2001; Bourque et al., 1994). I will now discuss some of the 
intrinsic factors in greater detail. 
1.1.2.2.2 Depolarizing afterpotentials (DAP) 
 
In MNCs the phasic bursts are triggered by long-lasting (1-3s) depolarizing afterpotentials 
(DAPs), which are independent of synaptic inputs (Andrew & Dudek, 1983). Following spikes, 
the summation of these DAPs results in long-lasting plateau potentials that last for tens of 
seconds and causes a generation of a burst (Andrew & Dudek 1983; Li & Hatton, 1997). The 
DAP is an activity-dependent current that plays a significant role in release of hormones from 
VP and OT-MNCs. For the sustained release of VP for water conservation, the MNCs adopt 
phasic pattern of bursts while the phasic pattern of firing in MNCs is regulated by membrane’s 
intrinsic properties (Andrew and Dudek, 1983). Both VP and OT- MNCs exhibit DAPs but VP-
MNCs differ in pattern and rate of firing from OT-MNCs and also have different magnitude of 
expression for DAP. More VP-MNCs (75%) display DAP as compared to OT-MNCs (32%) 
(Oliet & Bourque, 1992; Armstrong et al., 1994). The electrical activity of MNCs is regulated by 
many Ca
2+
 dependent pathways and increases or decreases of intracellular Ca
2+ 
[Ca
2+
]i regulate 
DAP generation, plateau potentials and phasic bursts in MNCs (Li et al., 1995). 
7 
 
Continuous firing in MNCs causes secretory fatigue which brings progressive decrease in VP 
secretion (Bicknell, 1988). MNCs undergo a silent phase of same length of burst for increased 
hormonal secretion. To avoid secretory fatigue, phasic bursts in VP-MNCs are terminated by the 
activation of some inhibitory currents including hyperpolarizing afterpotentials (HAP) and an 
afterhyperpolarizing afterpotential (AHP) (Armstrong et al., 1994). The exact mechanism of 
termination of phasic bursts is not completely known but these inhibitory currents may be 
involved in the regulation of DAP to sustain plateau potentials or phasic bursts (Andrew & 
Dudek, 1984; Roper et al., 2003). Both of the HAP & AHP are mediated by Ca
2+
 dependent K
+
 
channels and their main function is to regulate MNC firing rate and pattern (Andrew & Dudek, 
1984; Armstrong et al., 1994).  
Dynorphin and apelin, κ-opioid peptides are co-packaged in neurosecretory granules and co- 
released with VP during exocytotic fusion of granules with the plasma membrane from the 
somatodendritic regions of VP MNCs (Brown et al., 2006) by exocytosis (Pow and Morris, 
1989). Dynorphin may regulate VP release by interfering with phasic firing in the MNCs (Brown 
& Bourque, 2004; Brown et al., 2006).  
1.1.2.2.3 Stretch inactivated cation channels (SICs) in MNCs 
 
MNCs are intrinsically osmosensitive and regulate fluid homeostasis by releasing VP. Changes 
in osmolality cause the cells to shrink or swell in hyperosmolality or hypo-osmolality 
respectively (Oliet & Bourque, 1992). An increase in osmolality depolarizes the plasma 
membrane by the activation of stretch inactivated cation channels (SICs) and this causes the cells 
to fire (Oliet & Bourque, 1992; Sharif-Naeini et al., 2006). SICs are mechanosensitive channels 
expressed on the plasma membrane of MNCs and the osmotic changes in cell volume regulate 
these channels (Oliet & Bourque, 1993a; Oliet & Bourque, 1993b). Osmotically induced 
swelling or pipette pressure during patch clamp increases the membrane tension and closes the 
SICs, which leads to membrane hyperpolarization and makes firing of MNCs less likely. The 
SICs are opened due to the shrinkage of cells when exposed to hyperosmotic stimuli thereby 
increasing the likelihood of firing and increasing the hormone release caused by Ca
2+
 influx in 
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MNC terminals (Oliet & Bourque, 1992). The SICs are responsible for 60% of the input 
conductance of the MNCs at the physiological set point of osmolality (Bourque & Oliet, 1997). 
The SICs of MNCs belong to the transient receptor potential vanilloid (TRPV) family, a family 
of cation channels.  MNCs express an N-terminal splice variant of the TRPV1 gene that is found 
to be involved in the osmosensory transduction mediated by VP MNCs (Sharif-Naeini et al., 
2006). All TRPV channels are blocked by ruthenium red (RuR) and the osmosensitivity of 
MNCs was inhibited when the channels were blocked with RuR. The MNCs of TRPV1 knock 
out mice do not display osmotically- evoked depolarization. This clearly demonstrated the role of 
SICs in the osmosensory transduction in the MNCs (Sharif-Naeini et al., 2006; Sharif- Naeini et 
al., 2008b; Sudbury et al., 2010).  
 
MNCs are intrinsically thermosensitive and fire rapidly in response to increases in temperature to 
release more VP, but the central thermosensory mechanism for this regulation is not completely 
known. The thermosensitivity of VP neurons is regulated by the SICs (Sharif- Naeini et al., 
2008a). TRPV1 are temperature sensors (Benham et al., 2003) and expression of TRPV1 gene is 
required for the thermosensory transduction of VP release for the thermoregulation during 
hyperthermia (Sharif-Naeini et al., 2008a). A specific antagonist of TRPV1 channels to which 
they are sensitive is SB366791 and heat activated currents in VP-MNCs are blocked by this 
compound (Sharif-Naeini et al., 2008a). TRPV1 knock out mice displayed low thermosensitivity 
in VP-MNCs (Kanai et al., 2007; Sharif- Naeini et al., 2008a) 
 
SICs behave mechanically in response to osmosensation and this has been explained by 
observing the role of actin filaments on the mechanosensitivity of SICs in MNCs. Whole cell 
patch clamp recordings have showed the direct effect of actin- cytoskeleton on the SICs 
activation and inhibition because an actin depolymerizing compound called cytochalasin-D 
reduced the SICs mechanosensitivity and the actin filament polymerizing compound 
jasplakinolide increased it. The osmosensitivity of SICs therefore appears to depend on their 
interaction with the cytoskeleton (Zhang et al., 2007b). 
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1.2 Calcium channels 
 
Many cellular events are Ca
2+ 
dependent and Ca
2+ 
influx is brought about by specific ion 
channels called Ca
2+ 
channels. There are different Ca
2+ 
channels present on cellular plasma 
membranes including voltage gated calcium channels (VGCCs), transient receptor potential 
(TRP) channels, store operated channels or Ca
2+
 release-activated Ca
2+
 channels (CRACs), 
arachidonate- regulated Ca
2+ 
channels (ARC) and N-methyl D-aspartate receptors (NMDARs). 
Intracellularly, Ca
2+ 
is released by two types of receptors, which are ryanodine receptors and 
inositol 1, 4, 5-triphosphate receptors (IP3) (Striggow & Ehrlich, 1996). Ca
2+ 
is a second 
messenger (Petersen et al., 2005) and Ca
2+
 signaling is essential for cellular functions. Ca
2+ 
influx from the extracellular compartment and Ca
2+ 
storage and its release have important roles 
in various cell processes including health and disease (Berridge et al., 2003). Ca
2+ 
signaling is 
triggered by external stimuli in form of growth factor, hormone secretion, neurotransmitter 
release and membrane excitation in excitable cells (Siegel et al., 2006). Intracellular Ca
2+ 
is 
stored in the endoplasmic reticulum (ER) and contributes to the integrity of ER, which has a 
pump for its release called sarcoendoplasmic reticulum Ca
2+
-ATPase (SERCA) pump for its 
storage and release for different signaling pathways (Koch, 1990) and its concentration varies 
greatly from intracellular (~100 nM) to extracellular (mM) compartments. This concentration 
gradient is responsible for enhanced signaling events in cytosol (Clapham, 2007). Moreover the 
mitochondria, which is another store house for Ca
2+
, is also capable of regulating its important 
functions e.g. oxidative phosphorylation by the storage of Ca
2+
 (Zamponi, 2005). The 
depolarization of plasma membrane brings changes in [Ca
2+
]i by Ca
2+ 
influx through Ca
2+ 
channels and its rise in concentration acts as a chemical signal to trigger secretion and release of 
hormones and neurotransmitters and muscle contraction (McCleskey et al., 1986).  
1.2.1 Voltage-gated Ca2+ channels (VGCC) 
 
Ca
2+
 entry into cells through the plasma membrane occurs mostly by VGCC, which are found in 
excitable cells like myocytes, neurons, endocrine and neuroendocrine cells (but not in non-
excitable cells such as epithelial or most blood cells) and are activated by membrane 
depolarization (Siegel et al., 2006). These channels have high selective permeability to Ca
2+
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(Catterall, 2000). Upon depolarization of the plasma membrane, the VGCCs are opened causing 
Ca
2+
 influx, which acts as a second messenger of electrical signaling and initiates intracellular 
biochemical events through Ca
2+
 signaling pathways. This signaling is essential for different 
functions; in neurons for neurotransmission, in muscles for excitation-contraction, in 
neuroendocrine for excitation-secretion and gene expression (Catterall, 2000). These channels 
are heteromultimeric protein structures and each channel consists of a complex of four subunits 
an α1- subunit and three auxillary subunits (an intracellular β- subunit which serves for 
trafficking of ions, γ-subunit and a disulphide linked complex of α2 -δ). These four subunits are 
present in a 1:1:1:1 stoichiometry. The α1, largest amongst all subunits, is 190-250 KDa in its 
molecular mass and makes the Ca
2+
 selective conductance pore, a voltage sensitive gate for Ca
2+ 
influx. There are four homologous domains within each α1 subunit and each domain further 
comprises six transmembrane segments (S1 – S6). The function of voltage sensor is served by 
segment 4 (S4) and ion conductance is determined by the pore loop between segment S5 and S6. 
Electrophysiological studies have showed different types of VGCC which include L-, N-, P-, Q-, 
R- and T- types.  Ten genes of α1 have been discovered that fall into three major families, Cav1, 
Cav2 and Cav3. Similar biophysical and pharmacological characteristics of these families divide 
them in subfamilies; L-type (Cav1.1, Cav1.2, Cav1.3 and Cav1.4), P/Q-type (Cav2.1), N- type 
(Cav2.2), R-type (Cav2.3) and T-types (Cav3.1, Cav3.2 and Cav3.3) (Hofmann et al., 1999; 
Catterall, 2000; Jarvis & Zamponi, 2007). Formerly these channels were named as α1S (Cav1.1), 
α1C (Cav1.2), α1D (Cav1.3), α1F (Cav1.4), α1A (Cav2.1), α1B (Cav2.2), α1E (Cav2.3), α1G (Cav3.1), α1H   
(Cav3.2) and α1I (Cav3.3). The original nomenclature depended on the functional properties of 
different Ca
2+
 currents e.g. the L-type Ca
2+
 channels stands for long- lasting, T-type for tiny or 
transient, N-type for neither L nor T. P-type current was first discovered in Purkinje cells of 
mammals and in the presynaptic terminals of squid giant and R-type is named for resistant or 
residual, because it was insensitive to all current blockers at that time (Catterall, 2000; Fisher & 
Bourque, 1995; Hofmann et al., 1999; Joux et al., 2001).  
 
MNCs express all these channels either on somata or terminals or both. The N-type Ca
2+
 
channels are present on the somata and terminals of MNCs and they contribute 26- 40% of the 
total VGCC current, P-type Ca
2+
 channels are expressed only on the somata of MNCs which 
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makes a 20% of the total VGCC while Q- type are found only in the terminals, R-type channels 
are expressed on both somata and terminals and the T- types are expressed only in somata and 
not in the axon terminals (Fisher & Bourque, 1996; Catterall, 2000; Fisher et al., 2000; Joux et 
al., 2001).  
 
1.2.1.1 The L-type Ca
2+
 channels 
 
The long lasting L-type voltage gated Ca
2+
 (L-type Cav) channels belong to family Cav1 (Cav 1.1, 
Cav 1.2, Cav 1.3, Cav 1.4) of the α1 subunit. They are high voltage-activated Ca
2+
 channels and 
activate at voltages more positive than -40mV except for Cav1.3, which activates at voltages 
above -50mV (Fox et al., 1987; Koschak et al., 2001).  Primarily, the L-type Ca
2+
 channels are 
regulated by second-messenger regulated protein phosphorylation cascades. The four isoforms of 
Cav1 are found in various tissues of the body mainly muscles and neuroendocrine cells, where 
they regulate excitation-contraction and excitation-secretion coupling respectively. The L-type 
Ca
2+ 
channels are blocked by various organic antagonists such as benzothiazepines, 
phenylalkylamines and dihydropyridines. (Catterall, 2000; Fisher & Bourque, 2001; Triggle, 
2006).  
L-type Cav channels have roles in brain relating to neuronal development and survival, injury, 
synaptic plasticity, gene expression and neurotransmitter/hormone release (Lipscombe et al., 
2004). Cav1.2 and Cav1.3 are expressed predominantly in CNS and play significant roles in 
neuronal functions such as long term signal transduction events (Ahlijanian et al., 1990; Silver et 
al., 1990; Tanaka et al., 1995; Striessnig et al., 2006). Neuronal gene expression may be 
regulated by L-type Cav channels (Cav1.2 & Cav1.3) by the regulation of Ca
2+
/calmodulin-
activating transcription factors or by increased nuclear Ca
2+
 (Chung & Jan, 2006). Cav1.2 also 
acts as a transcriptional regulator when its C terminal is translocated as a signal to nucleus 
(Gomez-Ospina et al., 2006). Recent studies of Ca
2+ 
imaging have confirmed the localization of 
Cav1.2 and Cav1.3 in the mitotic apparatus of cells confirming their role in cell division 
(Loechner et al., 2009). Single cell RT-PCR and immunocytochemistry have identified both 
Cav1.2 and Cav1.3 in somata and dendrites of MNCs (Glasgow et al., 1999; Joux et al., 2001) 
and they contribute 23-28% of total VGCC currents observed in MNCs somata (Fisher & 
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Bourque, 1995, Fisher & Bourque, 1996; Foehring & Armstrong, 1996). L- type Ca
2+
 channels 
are also expressed on the internal membranes of cytoplasm other than plasma membrane of 
MNCs (Fisher et al., 2000; Joux et al., 2001). L-type Ca
2+ 
channels regulate gene expression in 
MNCs (Burbach et al., 2001) because the C-termini part of both Cav1.2 and Cav1.3 contain the 
sequences that specifically cause the channels to activate a transcription factor known as the 
CREB (cAMP response element binding) protein (Burbach et al., 2001). L-type Ca
2+
 currents 
mediate the somatodendritic release of dynorphin in hippocampal granule cells and this may be 
functionally similar to the secretion coupling in neuroendocrine cells (Simmons et al., 1995; 
Fisher & Bourque, 2001) 
 
1.3 SNARE mediated exocytotic fusion 
 
Cellular communication requires vesicle trafficking by the fusion of membranes, which requires 
a soluble NSF attachment receptor (SNARE) protein (Jahn & Scheller, 2006). NSF is N-ethyl-
maleimide–sensitive factor, an essential element of the protein machinery for exocytosis, 
endocytosis and transcytosis of vesicle fusion with the plasma membrane (Furst et al., 2003). 
NSF belongs to the ATPase family known as AAA, which stands for ATPases Associated with a 
variety of cellular Activities and is an 85 kDa protein inhibited by N-ethyl-maleimide (Hoyle et 
al., 1996). NSF is linked to a protein called soluble NSF attachment protein or α-SNAP, which 
causes NSF to disassemble the cellular machinery required for vesicle fusion (Matsushita et al., 
2005). There are three domains of NSF comprising the N-terminal domain, which facilitates the 
binding of NSF with α-SNAP, ATPase domain D1, which hydrolyses the ATP and brings 
conformational changes in the NSF, and ATPase domain DII, which is necessary for the 
hexamerization of NSF (Furst et al., 2003). The cellular machinery for vesicle fusion is a 
complex of various proteins including SNARE proteins, NSF and α-SNAP, Rab and Rab 
effectors, and members of the Sec1/Munc18 protein family (Matsushita et al., 2003; Matsushita 
et al., 2005). They together make a SNARE proteins complex and the disassembly of SNARE 
complex by NSF and α-SNAP is essential for its recycling (Furst et al., 2003; Matsushita et al., 
2003; Matsushita et al., 2005). The role of the SNARE protein complex has been observed as an 
essential element in almost all intracellular membrane fusions (Jahn & Scheller, 2006). 
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VP and OT secretion and release to the blood circulation is regulated by Ca
2+ 
dependent 
exocytotic fusion of peptide containing intracellular granule membrane with the plasma 
membrane of MNCs (Fisher & Bourque, 2001). The SNARE protein complex also regulates the 
exocytotic fusion of AQP2 channels with the apical membrane of renal collecting tubes on the 
release of VP for water reabsorption (Procino et al., 2008). The core of SNARE protein complex 
is made by three proteins, which are syntaxin-1, SNAP25 (synaptosome-associated proteins-25) 
and VAMP (vesicle associated membrane protein or synaptobrevin) and these three proteins 
together transport the exocytotic vesicle to the target plasma membrane (Sollner et al., 1993).  
There are two types of SNARE proteins, v-SNAREs (found on the secretory vesicle) and t-
SNAREs (present on target membrane) and both opposing SNAREs fuse the membranes 
together by assembling into a four helix bundle by using free energy released during bundle 
formation (Sutton et al., 1998; Jahn & Scheller, 2006). Calcium dependent exocytotic fusion of 
membranes for neuropeptide release is also regulated by some other proteins such as 
synaptotagmin (a Ca
2+
 binding protein), complexin and Munc18 or Sec1, which binds to the 
syntaxin at its N-terminus and detaches from it for syntaxin bonding with SNAP25 and VAMP 
for the formation of SNARE core complex (Dulubova et al., 2003; Procino et al., 2008). In 
neurotransmission, synaptotagmins catalyze the SNARE mediated exocytotic fusion by 
supplying energy and force but its exact role is not known in hypothalamic neurons for release of 
neuropeptides (VP and OT) (Gustavsson et al., 2009; Zhang et al., 2011). 
 
It was observed that L-type Ca
2+
 channels are selectively found in the lipid rafts of plasma 
membrane of the bovine chromaffin cells (Park & Kim, 2009). SNARE mediated exocytosis 
depends on the association of SNARE proteins with lipid rafts. L-type Ca
2+
 channels are 
involved in the exocytosis of large dense core vesicle for increase in neurotransmitter release by 
the regulation of protein kinase C (PKC) translocation and phosphorylation of myristoylated 
alanine-rich C kinase substrate (MARCKS) (Park & Kim, 2009). The L-type Ca
2+
 channels 
including Cav1.2, Cav1.3 have been found interacting with some of the proteins of SNARE 
complex such as syntaxin and SNAP-25 (Fisher & Bourque, 2001). The coexpression of syntaxin 
and synaptotagmin with L-type Ca
2+
 channels in Xenopus oocytes supported the involvement of 
Cav1.2 in the secretory process (Wiser et al., 1999). Immunocytochemistry has showed the 
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coexpression of syntaxin 1 and other vesicle-associated proteins with the Cav1.3 at the basal pole 
of hair cells (Song et al., 2003) and recently it has been presented that II & III interdomains of 
Cav1.2 and Cav1.3 interact with the exocytotic secretory machinery involved in glucose-mediated 
insulin secretion (Jacobo et al., 2009).  
 
It has been observed in endothelial cells that NSF-regulated exocytosis can be inhibited by fusion 
polypeptides known as TAT-NSF polypeptides composed of 11 amino acid human immuno-
deficiency virus (HIV) transactivating regulatory protein (TAT)  factor (Matsushita et al., 2005). 
The ATPase activity is inhibited by a membrane permeant NSF700-722 peptide of domain 2 of 
NSF by interfering with NSF hexamerization (Matsushita et al., 2003; Matsushita et al., 2005). 
NSF700 is fused to the 11-amino protein transduction domain of the HIV TAT protein to inhibit 
the exocytosis in cells (Morrell et al., 2005; Trang et al., 2009). This inhibiting protein domain 
showed permeability for the endothelial cell membrane where it is fused with 22 amino acid of 
NSF to block its action for exocytosis by inhibiting the NSF-ATP hydrolysis and NSF- 
disassembly activity (Matsushita et al., 2003; Matsushita et al., 2005). The scrambled version of 
NSF700–722 (TAT–NSF700scr) is used as control peptide that does not inhibit SNARE-
mediated exocytosis (Trang et al., 2009; Morrell et al., 2005). 
 
1.3.1 Neuropeptide secretion  
 
In MNCs, peptide secretion is achieved through regulated exocytotic fusion of large dense core 
granules (100-200 nm in diameter) like other neuroendocrine cells that are specialized to secrete 
large amount of neurosecretory products (Burgoyne & Morgan, 2003). The secretory granule 
exists in two forms before exocytosis, one is immature secretory granules with unregulated 
exocytotic carriers and the second is mature secretory granules with regulated exocytotic 
carriers. The secretory peptide is synthesized in the cisternae of rough endoplasmic reticulum 
(RER), packed and processed in cis- Golgi domain and finally in trans-Glogi network where it 
becomes a mature membrane- bound secretory granule or vesicle and ready for the fusion with 
plasma membrane for the hormone release. SNARE proteins such as Synaptotagmin IV (Syt IV) 
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and VAMP4 enter the immature granule but are removed during the switch from immature to 
mature large dense core granules (Boron & Boulpaep, 2009; Eaton et al, 2000).  
The hormones or neuropeptides are synthesized in the somata of MNCs in the form of secretory 
vesicles, then they are packed and released on the occasion of cell firing followed by the rise of 
[Ca
2+
]i by the Ca
2+
 influx through VGCC (Robinson & Martin 1998; Fisher & Bourque, 2001). 
The interaction between Ca
2+ 
channels and the exocytotic protein apparatus is an important 
determinant of activity-secretion coupling for neuropeptide release (Fisher & Bourque, 2001). N 
and P/Q channels (Cav2.1 and Cav2.1 respectively) interact with SNARE proteins such as 
syntaxin, SNAP-25, and synaptotagmin for neuropeptide release (Catterall, 1999) while L-type 
Ca
2+
 channels may be involved in the somatodendritic release of VP through exocytotic fusion 
(Shibuya et al., 1998; Fisher & Bourque, 2001). Microdialysis studies have showed that 
neuropeptides (VP & OT) are released in an activity-dependent manner from somatodendritic 
regions of MNCs and may have a significant role in the regulation of MNCs function (Ludwig et 
al., 2005; Ludwig & Leng, 2006). The somatodendritic regions of MNCs have been shown to 
have many large dense core granules through electron micrographs, and they can be induced to 
fuse with the plasma membrane (Pow & Morris, 1989). The somatodendritic release of 
neuropeptides has an autocrine role in hormone release as VP and OT-MNCs express their 
respective receptors and binding of peptides with their receptors cause increases in intracellular 
Ca
2+ 
(Dayanithi et al., 1996). Structural remodeling of the SON in non-lactating rats can be 
induced by giving them prolonged intraventricular infusion of OT, which suggests a role for 
somatodendritic release of OT during lactation and parturition (Theodosis et al., 2008). The 
somatodendritic release of both VP and OT do not parallel axonal release but it is important in 
regulation of cellular activity and can modulate synaptic inputs on MNCs (Ludwig et al., 2002; 
Ludwig et al., 2005). Endogenous peptides like dynorphin and apelin are co-stored and co-
released with VP and have inhibitory effects on VP release (Brown et al., 1999) and dynorphin 
may have a role in termination of phasic bursts in VP-MNCs (Brown & Bourque, 2004). 
Immunocytochemistry studies have shown coexpression of dynorphin with VP secretory 
granules (Shuster et al., 2000). Dynorphin inhibits the VP release through acting on kappa- 
opioid receptors, which are co-localized on VP-MNCs in hypothalamic nuclei as well as in the 
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posterior pituitary. These receptors are translocated to the plasma membrane during exocytotic 
fusion of large dense granule in a stimulus-dependent fashion (Shuster et al., 1999).  
 
1.4 Morphological identification of MNCs after isolation 
Methods have been developed to isolate MNCs (Armstrong et al., 1994; Oliet & Bourque, 1992) 
and it was seen that isolated MNCs contain short processes (<30µm), are oblong shaped, and 
look bright under phase contrast (Silverman & Zimmerman, 1983). It was estimated that 100 to 
500 MNCs are isolated from each tissue block of SON after enzymatic digestion, which is 2-10% 
of the total number of cells (Oliet and Bourque, 1992). To determine whether neurons isolated 
from SON are MNCs, a criterion depending on the cross sectional area (CSA) of cells was 
developed (Oliet and Bourque, 1992). It was observed that more than 96% of cells had CSA 
>160µm² were specifically immunoreactive to either OT or VP carrier proteins (NI or NII, 
respectively) (Oliet & Bourque, 1992). 
 
 1.5 Osmotic changes in MNCs 
 
1.5.1 Short term osmotic changes and cell volume 
 
Osmotically-evoked cell volume changes always remain a challenge for the brain. MNCs are 
intrinsically osmosensitive and change their cell volume as a function of change in external 
osmolality (Oliet & Bourque, 1992). Also mechanosensitive SICs are activated by changes in 
osmolality and this enables the MNCs to respond electrically to changes in membrane tension 
(Oliet & Bourque, 1993b). The osmotically-induced cell shrinkage releases membrane tension, 
activates SICs and thereby depolarizes the cell membrane and increases cell firing and 
neuropeptide release (Fig 1) (Oliet & Bourque, 1993a). While the swelling of cells inhibits cell 
firing and hormone release by hyperpolarizing the membrane potential as SICs are closed due to 
increase in membrane tension (Fig 1) (Bourque & Oliet, 1997). 
 
Cell conductance is the ease with which ions flow across the plasma membrane through ion 
channels (Rhoades & Bell, 2009). Shrinkage of MNCs on exposure to a hyperosmolar stimulus 
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increases the conductance of the cell and swelling in response to a hypo-osmolar stimulus 
decreases the conductance of MNCs (Bourque & Oliet, 1997). A brief exposure of MNCs to 
hypertonic stimulus evoked conductance changes in only 90 sec by regulating the cell volume 
through mechanosensitive channels (SICs) (Bourque & Oliet, 1997).  This has been observed in 
both osmotically-induced cell volume changes and also changes evoked by pipette suction or 
inflation. These volume and conductance changes are reversible as soon as the stimuli are 
removed (Bourque & Oliet, 1997).  
 
In most cells, the osmotically-evoked cell volume changes (shrinkage & swelling) are regulated 
by compensatory mechanisms. Such regulations include regulatory volume increases (RVI) or 
regulatory volume decreases (RVD) on shrinking or swelling respectively, and regulate internal 
osmolality by ion transport and accumulation of organic osmolytes. These regulations are 
essential for increasing or decreasing internal osmolality with respect to changes in external 
osmolality to avoid potentially deleterious cell volume changes (Lang, 2007). 
Cell capacitance is the charge holding capacity of the plasma membrane, which acts as a 
capacitor to separate the ions of inside and outside compartments (Rhoades & Bell, 2009). The 
input capacitance of MNCs is directly proportional to the total membrane surface area of cell 
(Fernandez et al., 1984). Zhang & Bourque, 2003 studied short term osmotic changes during 
slow and fast osmotic ramps in MNCs. Slow osmotic ramps for 60 minutes caused slow and 
gradual shrinkage and swelling in response to hypertonic and hypotonic stimuli respectively, 
while fast osmotic changes of 10 minutes evoked volume changes within a minute and were 
maximal within 4 min (Zhang & Bourque, 2003). MNCs undergo shrinkage or swelling after 
acute hyper or hypo-osmotic stimuli exposure respectively and maintain these changes in volume 
during a 10 minute step change in osmolality. Hippocampal neurons also show acute 
osmotically-induced volume changes but they either recover their volume with osmotic decrease 
or respond slowly than the MNCs with an osmotic increase. This suggests that unlike MNCs, 
hippocampal neurons exhibit volume compensatory mechanisms (RVI and RVD) in response to 
osmotic changes (Zhang & Bourque, 2003). Whole cell patch clamp recordings showed changes 
in input capacitance in hippocampal neurons in response to osmotic changes but not in MNCs, 
which suggests that hippocampal neurons regulate their total membrane surface area either by 
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exocytotic fusion or endocytotic removal of membranes during osmotic stress. During short term 
osmotic changes, the sustained osmotically-evoked volume changes in MNCs are not the result 
of changes in total membrane surface area, as there is no change in input capacitance (Zhang & 
Bourque, 2003). This may be explained by the presence of membrane reserves in MNCs that 
increase in size when MNCs shrink and decrease in size when MNCs swell (Zhang & Bourque, 
2003). MNCs lack volume regulation in response to acute osmotic changes and only cell size 
expands or contracts (due to presence of elastic compartments within membrane) when the 
membrane tension increases or decreases, respectively without changing the total membrane 
surface area (Zhang & Bourque, 2003).  On the basis of these observations it was suggested that 
membrane reserves may regulate cell volume changes (shrinking & swelling) in response to 
osmotically-evoked changes in membrane tension which ultimately activate SICs in 
cytoskeleton-dependent fashion (Zhang & Bourque, 2003; Zhang et al., 2007b; Bourque, 2008).   
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         A                
                  B       
Figure 1: Change in cell volume in response to change in osmolality of MNCs. MNCs are 
intrinsically osmosensitive and changes in osmolality regulate their cell volume as they do not 
have RVI or RVD. A: Hypo-osmolar solution causes the MNCs to swell, stretch inactivated 
channels are closed due to increase in membrane tension and there is less ions transport; MNCs 
regulate normal flow of ions when osmolality is normal and maintain their size; MNCs shrink in 
volume due to hyperosmolar solution and there is increase ions flow. B: Stretch inactivated 
channels are expressed on MNCs which regulate the MNCs volume in response to change in 
osmolality. MNCs exhibit slow irregular firing when osmolality is normal or isotonic, there is 
slow firing when cell undergo hypoosmolar solution and fire rapidly when exposed to hypertonic 
solution. (Bourque, 2008; Bourque & Oliet, 1997) (Reproduced with permission from Copyright 
Clearance Center) 
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1.5.2 Long term osmotic changes  
 
The HNS undergoes sustained osmotically-induced structural and functional plasticity occurring 
on minutes to hours time scale during sustained dehydration (Hatton, 1997). These changes 
include retraction of astrocytic processes surrounding the MNCs, increased synaptic 
innervations, increased synaptic inputs of excitatory noradrenergic and glutamatergic 
neurotransmitters and decreases in gliotransmitter and taurine release and in GABAergic inputs. 
MNCs adopt direct and tight apposition with each other and also exhibit hypertrophy. These 
changes reverse when the external osmotic stimulus is removed or hormone secretion (VP or 
OT) returns to its basal level (Hatton, 1997).  
 
At basal conditions when the osmolality of external ECF is normal, both VP and OT- MNCs 
somata and dendrites are separated by fine astrocytic processes but hyperosmotic stimuli remove 
these processes. This glial retraction causes the direct and tight apposition of MNCs with each 
other. The juxtaposed neurons experience increased synaptic transmission with an increased 
number of multiple synapses (Theodosis et al., 2004). MNCs undergo hypertrophy (Hatton, 
1997, Theodosis et al,. 2004; Di & Tasker, 2004; Zhang et al., 2007a; Theodosis et al., 2008) 
during chronic dehydration, lactation and parturition. The interaction of astrocytes and neurons 
in the HNS is a very important feature for structural and functional changes to occur in response 
to chronic changes in HNS and the retraction is more extensive depending on the duration of 
stimuli. The cellular mechanism involved in this structural remodeling remains unclear 
(Theodosis et al., 2008).  
 
Previous literature showed a wide variety of experiments to see the response of HNS exposed to 
osmotic stimuli for chronic or longer term (Hatton, 1997). It has been observed that stress- 
mediated synaptic events also regulate the structural plasticity during long term osmotic changes 
and MNCs respond to osmotic changes by the regulation of cell volume during dehydration or 
salt loading (Hatton, 1997). The ultrastructural changes can be evoked in the experimental 
animals either by addition of salt to the drinking water for 7-10 days or by water deprivation. 
Both of these treatments take hours to days for the development of structural changes but 
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injection of hypertonic solution can evoke structural plasticity within 5 hours (Beagley & Hatton, 
1992; Hatton, 2002; Hatton, 1997) and increased dendritic bundles and glial retraction can be 
observed in 30 minutes after the transcardial perfusion of hypertonic solution (325 mOsmol kg
-1
) 
(Tweedle et al., 1993). The MNCs showed a 25% increase in capacitance after 16-24 hours of 
water deprivation, which suggests an increase in total membrane surface area through exocytotic 
membrane fusion (Zhang et al., 2007a). Electron microscopy of SON showed that somatic 
surface area of MNCs is increased by 70% during chronic dehydration of 10 days with 2% NaCl 
in rats (Modney & Hatton, 1989). This increase in surface area is also accompanied by a 15 fold 
increase in membrane apposition of adjacent MNCs during dehydration. This data also suggested 
a significant increase in the multiple synapses made between soma-somatic and somatodendritic 
contacts (Modney & Hatton, 1989). Electrophysiological and immunohistochemical findings 
showed a 20% increase in neuronal surface area and a 30% increase in glutamatergic and 
GABAergic innervation on VP and OT-MNCs during chronic dehydration caused by 2% NaCl 
for 7 days in rats and VP and (Di & Tasker, 2004). Whole cell patch clamp recording showed 
33% increase in cell capacitance of rats dehydrated for 7 days with addition of 2% salt in their 
drinking water (Tanaka et al., 1999). All these changes due to dehydration are reversible with 
rehydration for similar time periods (Hatton, 1997). 
 
Long term dehydration causes up-regulation of VP genes (Zingg et al., 1986) and an increase in 
central VP receptors (V1a) (Hurbin et al., 2002). Water deprivation of 3 days in rats caused an 
increase in plasma osmolality and a 16% decrease in plasma volume as well as an increase in 
gene transcription of VP (Hayashi et al., 2006). Chronic dehydration caused increased 
expression of different receptors and channels e.g. dynorphin receptors (Shuster et al., 1999), L-
type Ca
2+
 channels (Zhang et al., 2007a) and Na
+
 channels (Tanaka et al., 1999). Dynorphin 
binding kappa- opioid receptors are translocated from large dense granules to plasma membrane 
through exocytotic fusion in response to hyperosmotic stimulus (Shuster et al., 1999).  
 
A whole cell patch clamp experiment carried out in our laboratory showed an 80% increase in 
nifedipine-sensitive (L-type Ca
2+
)
 
currents in both VP & OT-MNCs acutely isolated from rats 
dehydrated for 16-24 hours, while other types of Ca
2+ 
currents were not affected (Zhang et al., 
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2007a). Radioligand binding showed an increase in the density of L-type Ca
2+
 channels (Zhang 
et al., 2007a). This study could not resolve whether Cav 1.2 or Cav 1.3 or both is responsible for 
the increase in L-type Ca
2+
 current increase (Zhang et al., 2007a). An increase in L-type Ca
2+
 
channel, Cav1.2 was observed in pituicytes of rats which were chronically dehydrated (Wang et 
al., 2009). The mechanism underlying the increase of L-type Ca
2+
 currents and increased density 
of L-type Ca
2+
 channels is not clear. The increase of L-type Ca
2+
 current that occurs during long 
term osmotic increases may be important for the sustained high level of hormone release in 
several ways. The increase in L-type Ca
2+
 currents may affect the cell firing patterns (making 
them shorter and faster) through enhanced activation of Ca
2+
 dependent currents (DAP, slow and 
medium AHP).  MNCs respond to changes in dehydration with increase in gene expression and 
L-type Ca
2+
 channels are involved in the activation of a transcription factor (CREB) (Burbach et 
al., 2001) which suggests that the increase in L-type Ca
2+
  currents could result in increased gene 
expression. It has been hypothesized as well that somatodendritic release may be significant for 
long term osmotically-evoked changes in MNCs and the increase in L-type Ca
2+
 channels may 
enhance the somatodendritic release of VP & OT and other co-released peptides (dynorphin & 
apelin) during physiological osmotic stress. The increased density of L-type Ca
2+
 channels could 
be explained by an increase in the synthesis of channels or the translocation of existing channels 
(Zhang et al., 2007a). 
 
1.5.2.1 Hypertrophy  
 
Many cells regulate their surface membrane area in response to osmotic changes. This regulation 
tends to resist changes in membrane tension and is known as surface area regulation (Morris & 
Homann, 2001). Increase in membrane tension due to hypo-osmolar stimuli causes an insertion 
of new membrane from cytoplasmic reserves while a decrease in tension in hyperosmolar stimuli 
tends to result in uptake of membrane into internal reserves. MNCs undergo hypertrophy when 
exposed to long term hyperosmolality or chronic dehydration, which is opposite to this 
phenomenon. In lactation and parturition only OT neurons show these ultrastructural changes 
while in chronic dehydration both OT and VP neurons undergo hypertrophy (Hussy, 2002). 
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Preliminarily findings in our lab suggest that MNCs acutely isolated from normally hydrated rats 
can show hypertrophy in response to a 30 mOsmol kg
-1
 rise of external osmolality over the 
course 2.5 hours in vitro (unpublished data). Increased osmolality initially decreased the CSA of 
MNCs as it was predicted according to Zhang & Bourque, 2003 but this followed by an 
enlargement of CSA over the following two hours. This change was reversed when the bathing 
solution was replaced with isotonic solution. This enlargement in CSA was not found in the 
hippocampal neurons or dorsal root ganglion cells suggesting that hypertrophy is a unique 
adaptation of MNCs. Different experiments have been done to see how hypertrophy in MNCs is 
regulated. For that purpose MNCs were treated with different blockers before exposure to 
hyperosmolar solution. Hypertrophy was prevented by pretreatment of the cells with tetrodotoxin 
(TTX), which blocks Na
+
 channels and therefore blocks action potential firing. Hypertrophy was 
also blocked by SB366791 (SICs blocker; Sharif-Naeini et al., 2008a), nifedipine (L-type Ca
2+
 
channel blocker) or BAPTA-AM (which chelates intracellular Ca
2+
) (unpublished data).  This 
data suggests that hypertrophy of MNCs is dependent on the activation of Na
+
 channels, SICs  
and Ca
2+ 
influx through L-type Ca
2+ 
channels (unpublished data). Our lab also observed that 
hypertrophy is reversed if hypertrophied cells incubated in hyperosmolar solution are treated 
with TTX or SB366791 or nifedipine. These data suggest that hypertrophy occurs through the 
following sequence of events. An increase in osmolality shrinks the cells, which leads to the 
activation of SICs, which increases the cell firing and Ca
2+ 
influx through L-type Ca
2+ 
channels 
and ultimately results in hypertrophy of MNCs (unpublished data). There is still need to know 
the physical and biochemical changes to understand mechanism of this hypertrophy in MNCs 
that may facilitate the sustained and high level of hormone release. 
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CHAPTER 2 
 
HYPOTHESIS AND OBJECTIVES 
 
The structural and functional adaptations that occur in MNCs in response to sustained increases 
in osmolality may be important for maintaining high VP concentrations when its demand is 
increased (Hatton, 1997). One part of these adaptations is hypertrophy of the MNCs. 
Electrophysiological and radioactive ligand binding studies showed that increases in osmolality 
also cause an increase in L-type Ca
2+
 channels (Zhang et al., 2007a). Little is known about the 
mechanisms of either of the hypertrophy or the increase in L-type Ca
2+
 channels because it is 
difficult to address these questions in whole animal experiments. Most of the observations have 
been taken from in vivo studies in which induction of hyperosmolality takes a long time and the 
mechanism of hypertrophy cannot be studied easily. We therefore decided to study hypertrophy 
in in vitro experiments and found that this phenomenon may be observed in MNCs acutely 
isolated from rats in tissue culture. On the basis of this preliminary information we designed two 
hypotheses; 
1. Hypertrophy, a structural and functional adaptation of MNCs to sustained increases in 
external osmolality, may be due to the insertion of new membrane through the exocytotic 
fusion of intracellular granules with the plasma membrane of MNCs.  
2. Sustained increases in osmolality increase expression of L-type Ca2+ (Cav1.2 and Cav1.3) 
channels in isolated MNCs. 
 
The objectives of this study are to understand the mechanisms of osmotically-induced 
hypertrophy in MNCs and of the increase in the L-type Ca
2+
 channel density in response to 
increased osmolality.  
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CHAPTER 3                                                                                               
MATERIALS AND METHODS 
3.1 Chemicals 
All chemicals, unless stated otherwise, were from Sigma (St. Louis, MO).  The TAT-NSF700 
peptide and its scrambled version were purchased from AnaSpec, Inc. (Fremont, CA). Primary 
antibodies including Neurophysin I, II were from Santa Cruz Biotechnology, CA while Cav1.2, 
1.3 were from Alomone laboratories, Israel. Secondary antibodies were Cy3-labeled antigoat 
from Jackson ImmunoResearch laboratories, PA and Alexa Fluor 555 antirabbit were from 
Invitrogen, CA.  
3.2 Animal and cell preparation 
Normally hydrated Male Long Evans rats (Charles River, QC, Canada) weighing 250-300g, were 
used for all experiments. According to the guidelines of the Canadian Council on Animal Care 
and our University Ethics committee, the rats were anesthetized by halothane inhalation and 
killed by decapitation. The brain was then removed from the skull carefully, placed onto Petri 
dish and moistened with PIPES (piperazine-1, 4-bis (2-ethanesulfonic acid) solution composed 
of (in mM, pH 7.1): PIPES 20, NaCl 110, KCl 5, MgCl2 1, glucose 25 and CaCl2 1 (abbreviated 
as PGC). The osmolality of the PGC was maintained at 295 mOsmol kg⁻1 ±3 throughout using a 
VAPRO pressure osmometer (WESCOR, Logan, UT, USA) by adding mannitol as required.  
Hyperosmotic solution was maintained at 325 mOsmol kg
-1 
in our experiments. Increases of 
osmolality of this magnitude were used to characterize the SICs (Oliet & Bourque, 1993a; Oliet 
& Bourque, 1993b) and have been used in our lab to cause osmotic changes in MNCs isolated 
from rats (Zhang et al., 2009; Wang et al., 2009).  A brain slice of approximately 1.0 mm 
thickness containing most of the supraoptic nuclei was excised and shifted to a dish in isotonic 
PGC. The slice was fixed with pins and two tissues containing most of the SON were cut from 
the slice using an inverted microscope. Tissue blocks were put into 10 ml of PGC with trypsin 
(Type XI, 0.6 mg/ml) in a 15 ml glass tube and bubbled with 100% O2 in a water bath at 30
o
C for 
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90 minutes and then shifted to trypsin free PGC at room temperature for 30 minutes with the 
continued supply of O2. Tissue blocks were triturated by a series of fire polished Pasteur glass 
pipettes with decreasing diameters. Finally, the MNCs were plated on the glass bottomed culture 
dishes (Fisher & Bourque 1995; Fisher et al., 2000). To avoid evaporation the dishes were 
covered and cells were allowed to settle down and adhere to the bottom of dishes for half an hour 
at room temperature before doing experiments. 
3.3 Hypertrophy response 
 
Acutely isolated MNCs were photographed at 0 minute with a cooled CCD camera attached to a 
Zeiss Axiovert 200 using a 40X objective in a solution that is close to the normal set point of 
extracellular osmolality in the rat (295 mOsmol kg
-1
) and then rapidly shifted to a hyperosmolar 
solution (325 mOsmol kg
-1
). The MNCs were photographed at a time interval of 15, 30, 60, 90, 
120 and 150 minutes. Finally the cells were returned to media of normal osmolality and 
photographed at 180 and 210 minutes. The maximal circumference of the cell somata was traced 
using the software Image J (NIH) which then gives the cross sectional area (CSA) of the cells in 
pixels which can then be converted to area in µm
2
.    
3.4 Whole-cell patch clamp recording 
An EPC-9 amplifier (HEKA Elektronik, Lambrecht/Pfalz, Germany) was used for performing 
whole cell patch clamp recording at room temperature. The micropipettes (1.2 x 0.68 mm, A-M 
Systems Inc., Carlsborg, WA, USA) were prepared by using a P-97 horizontal pipette puller 
(Sutter Instrument Company, Novato, CA, USA). A microforge (Narashige, Tokyo, Japan) was 
used to fire-polish the micropipettes. The recording electrodes (4-6 M) were filled with an 
internal solution (pH 7.34) containing (in mM): K-gluconate 120, MgCl2 1, EGTA 1, HEPES 10, 
Na2ATP 4, and Na-GTP 1 (adjusted to 265 mOsmol kg
-1
).  There were two groups of MNCs 
used for whole cell patch clamp. In one group the cells were incubated with isotonic PGC (295 
mOsmol kg
-1
) and for second in hyperosmolar (325 mOsmol kg
-1
) for 90-150 minutes.   
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3.4.1 Measurement of cross sectional area (CSA) of MNCs  
 
Cells were photographed before whole cell patch clamp for taking Cslow with a cooled CCD 
camera attached to a Zeiss Axiovert 200 using a 40X objective.  In the software Image J (NIH), 
the maximal circumference of the cell somata was traced with the mouse which then gives the 
cross sectional area (CSA) of the cells in pixels which can then be converted to area in µm
2
.    
3.4.2 Cell capacitance 
 
Whole cell capacitance was measured using the Cslow function of the PULSE software (HEKA, 
Germany). The Cslow represents the input capacitance of cell according to the software while Cfast 
is for capacitance of the electrode which was cancelled before taking the Cslow. The cells having 
a CSA greater than 160 µm
2
 were considered as MNCs (Oliet &Bourque, 1992) for taking 
capacitance through whole cell patch clamp recording.  
3.5 Hypertrophy with TAT peptide  
 
A recently developed TAT (human immunodeficiency virus transactivator of transcription) 
peptide (TAT-NSF700; H-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Gly-Gly-Gly-Leu-
Leu-Asp-Tyr-Val-Pro-Ile-Gly-Pro-Arg-Phe-Ser-Asn-Leu-Val-Leu-Gln-Ala-Leu-Leu-Val-Leu-
OH) that prevents SNARE-mediated exocytotic fusion by blocking the function of NSF (N-
ethylmaleimide-sensitive factor) (Matsushita et al., 2003; Matsushita et al., 2005) was used in 
hypertrophy experiments. MNCs were preincubated with TAT peptide (5µg/ml) for an hour prior 
to take photographs. Cells were photographed at 0 minute in isotonic PGC (295 mOsmol kg
-1
) 
similary as done in hypertrophy experiments and then shifted to hyperosmolar solution (325 
mOsmol kg
-1
) and photographed at 15, 30, 60, 90, 120 and 150 minutes. Then cells were shifted 
to isotonic solution and photographed at 180 and 210 minutes. Other dishes of MNCs were 
preincubated with scrambled TAT peptide (TAT-NSF700scr;  H-Tyr-Gly-Arg-Lys-Lys-Arg-
Arg-Gln-Arg-Arg-Arg-Gly-Gly-Gly-Ile-Pro-Pro-Val-Tyr-Phe-Ser-Arg-Leu-Asp-Leu-Asn-Leu-
Val-Val-Leu-Leu-Leu-Ala-Gln-Leu-OH) with the same procedure to act as control. 
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3.6 Immunocytochemistry  
 
All procedures used in these experiments were in accordance with the guidelines of the 
University of Saskatchewan Animal Care Committee. MNCs were isolated from Male Long 
Evans rats by using the protocol described earlier, except poly-L-lysine coated dishes were used. 
After isolation the cells were treated with hyperosmolar solution (PGC= 325 mOsmol kg
-1
) for 2 
hours and washed briefly with PBS. The cells were fixed for 20 minutes at room temperature 
with ice cold methanol (100%), which also serves to permeablize the cells. The cells were rinsed 
three times with PBS  and treated with blocking solution containing 10% donkey serum in 
antibody diluent i-e; 1% BSA in PBS for 30 minutes. Then cells were incubated with primary 
antibody overnight at 4˚C following three washes with PBS. Goat antibodies directed against 
neurophysin I (1: 100) and neurophysin II (1: 100), which identify OT and VP releasing MNCs 
respectively, were used as primary antibodies (Santa Cruz Biotechnology). To target L-type Ca
2+
 
channels (both Cav1.2 & Cav1.3), rabbit antibodies Cav1.2 (1:200) and Cav1.3 (1:200) from 
Almone laboratories were utilized. Next day the dishes were rinsed three times with PBS and 
then incubated with secondary antibodies for 1 hour. The secondary antibodies used were Alexa 
fluor 488 donkey anti-goat (1:500) and Alexa fluor 555 donkey antirabbit (1:200) from 
Invitrogen. The cells were again rinsed with PBS for three times and then stained with Hoechst 
stain (2µl/1ml of PGC) for 10 minutes followed by PBS washing. A mounting solution 
(Citifluor, Marico) was added at the end. Cells were viewed using a Zeiss inverted Axiovert- 200 
microscope with 40X objective using DIC and fluorescence imaging with appropriate filter sets. 
Images were captured using a cooled CCD camera and the mean intensity of fluorescence was 
measured using software Image J software by drawing an outline around the circumference of 
cell bodies. Mean grey value was selected in image J to measure mean intensity of 
immunofluorescence which was then converted to intensity in arbitrary units per µm
2
 for 
analysis. The negative controls were having no primary antibodies. Six different types of 
combinations were used to target L-type Ca
2+
 (Cav1.2 & Cav1.3), VP-MNCs (N II) and OT (NI) 
MNCs in control and dehydrated cells. Combinations and concentration of antibodies, treated 
with control and hypertonic PGC are given in table 3.1 below.  
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TABLE 3.1 Combination of antibodies used in immunucytochemistry 
 
 Combinations Concentration of 
primary 
antibodies 
Concentration of 
secondary antibodies 
1 Cav1.2, NI, NII Cav1.2 = 1:200 
NI= 1: 100 
NII= 1:100 
Donkey anti rabbit  1:200 
Donkey anti goat  1:500 
2 Cav1.2 NI Cav1.2 = 1:200 
NI = 1: 100 
Donkey anti rabbit  1:200 
Donkey anti goat 1:500 
3 Cav1.2, NII Cav1.2 = 1:200 
NII = 1: 100 
Donkey anti rabbit  1:200 
Donkey anti goat 1:500 
4 Cav1.3, NI, NII Cav1.3= 1:200  
NI= 1: 100 
NII= 1:100 
Donkey anti rabbit 1:200 
Donkey anti goat 1: 500 
 
5 Cav1.3, NI Cav1.3= 1:200 
NI= 1: 100 
 
Donkey anti rabbit 1:200 
Donkey anti goat 1: 500 
 
6 Cav1.3, NII Cav1.3= 1:200 
NII = 1: 100 
 
Donkey anti rabbit 1:200 
Donkey anti goat 1: 500 
 
Table3.1: L-Type Ca
2+
 channels (Cav1.2 & Cav1.2), Neurophysin I (NI) and Neurophysin II 
(NII) 
 
3.7 Data analysis 
Quantitative data were entered to Graph Pad Prism or Excel worksheets and the Student t-test 
was used to determine statistical significance with a confidence level of p < 0.05. All results are 
displayed as a mean ± standard error of the mean (SEM).  
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CHAPTER 4 
RESULTS 
MNCs undergo hypertrophy as a result of long term hyperosmotic stimulation of experimental 
animals caused by either water deprivation or salt loading (Hatton, 1997). Previous work in our 
lab showed that MNCs isolated from rats following overnight water deprivation had a whole cell 
capacitance that was 25% larger than that of MNCs isolated from normally hydrated rats (Zhang 
et al., 2007a) and recently an in vitro study in our lab showed that treatment of isolated MNCs 
with hyperosmolar solution for 2.5 hours displayed hypertrophy (unpublished data). My work 
had four objectives; First of all we tested for osmotically-induced hypertrophy in acutely isolated 
MNCs from normally hydrated rats to replicate lab findings. Second, whole cell patch clamp was 
used to test whether 2.5 hours of cells treatment with hypertonic solution causes a change in total 
cell capacitance. The third objective was to test whether hypertrophy could be prevented with 
TAT-NSF peptide, which blocks SNARE- mediated exocytotic fusion (Matsushita et al., 2005) 
and to confirm presence of new membrane insertion during osmotic stress in MNCs. Fourth and 
last; because L-type Ca
2+
 current is increased after dehydration in MNCs (Zhang et al., 2007a), 
we tested whether there is increase in  immunoexpression of L-type Ca
2+ 
channels (Cav1.2 and 
Cav1.3) by using specific antibodies targeted against these channels in MNCs acutely isolated 
from normally hydrated rats treated with isotonic or hypertonic solution.  
4.1 Osmotically-induced hypertrophy in isolated MNCs 
Acutely isolated MNCs (n = 12; from three separate preparations) from normally hydrated rats 
were rapidly shifted from a solution that is close to the normal set point of extracellular 
osmolality in the rat (295 mOsmol kg
-1
) to a hyperosmolar solution (325 mOsmol kg
-1
) and the 
CSA was monitored. After 15 minutes, CSA was found to be reduced from 455 ± 15 µm
2
 to 409 
± 16 µm
2
; P < 0.001 with a paired t-test. This represents a decrease of about 10%, which is 
consistent with the predicted shrinkage in cell size in response to acute hyperosmotic treatment 
(Zhang & Bourque, 2003). Over the following 135 minutes MNCs displayed an expansion to 496 
± 16 µm
2
, which was found statistically significant (P < 0.001 with a paired t-test; compared to t 
= 0). This is an increase of 9% compared to their original CSA. Cell size was compared to the 
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shrinkage state (t=15 minutes), which showed a 21% increase in CSA that was extremely 
significant P < 0.001). When the MNCs were returned to media of normal osmolality at 150 
minutes, the cells shrunk (452 ±14 µm
2
 at 180 minutes to 438 ± 16 µm
2 
at
 
210 minutes P > 0.05) 
to a size not significantly different than that at time 0 minute. The results are plotted below in 
Figure 4.1. This suggests that MNCs undergo hypertrophy in hypertonic solutions and that this 
process reverses when the cells are returned to solutions of normal osmolalities. Our in vitro 
results of hypertrophy may correspond to the process in vivo (Hatton, 1997; Tanaka et al., 1999; 
Di & Tasker, 2004; Zhang et al., 2007a) and allow us to study the mechanism. 
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Figure 4.1 Hypertrophic Response of MNCs. The cells were photographed at 0 minute in 
normal osmolality solution (295 mOsmol kg
-1
) and then subjected to hyperosmolar 
solution (325 mOsmol kg
-1
) for 150 minutes. Photographs were taken at the indicated 
times and then shifted to normal osmolality solution for 60 minutes. Images were 
analyzed using Image J (NIH) software. The cells showed rapid drop in CSA at 15 
minutes but then there was a gradual increase in size that was maximum at 150 minutes. 
The hypertrophy was recovered when the cells were returned to the solution of normal 
osmolality. 
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4.2 Effect of increased osmolality on whole cell capacitance                        
In order to observe the association between hypertrophy of MNCs and their total increase in the 
membrane, we tested whether MNCs treated with hypertonic solutions showed an increase in 
observed CSA and total cell capacitance. MNCs acutely isolated (Figure 4.2) from 6 normally 
hydrated rats were incubated in normal (295 mOsmol kg
-1
; n=21) and hyperosmolar (325 
mOsmol kg
-1
; n=23) solutions. The MNCs were photographed prior to whole cell patch clamp 
with a cooled CCD camera attached to a Zeiss Axiovert 200 using a 40X objective and the CSA 
was measured and analyzed using Image J (NIH). The mean CSA of the MNCs that were 
subjected to whole cell patch clamp was 276 ± 11 µm
2
 (in normal solution) and 305 ± 17 µm
2
 (in 
hyperosmolar solution) (Figure 4.3), which was not found to be statistically significant P > 0.05 
with an unpaired t-test. The CSA was found to be 10.5% higher for the hyperosmolar group as 
compared to the control group. The increase in CSA was observed immediately before 
measuring capacitance of the MNCs incubated in hyperosmolar solution for 90-150 minutes. 
This small increase in CSA of MNCs after treatment with hyperosmotic solution is consistent 
with the results shown in Figure 4.1, in which we found 9% increase in CSA at 150 minutes after 
treatment of cells with hyperosmotic solution. This difference was significant because those 
experiments followed the change in size of individual MNCs (and therefore we used a paired t-
test) whereas the unpaired data did not show a significant difference due to large range of sizes 
of MNCs.    
 
  
33 
 
                       
Figure 4.2 An acutely isolated MNC from SON of male Long Evans rat showing a typical 
image of a cell with three dendrites and somata in hyperosmolar solution (325 mOsmol kg
-1
) 
before patch clamp recording. Scale bar is 15 µm. 
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Figure 4.3 Cross sectional area (CSA) of MNCs treated with normal and hyperosmolar 
solution. The mean CSA of MNCs was measured from two groups of MNCs treated with control 
(295 mOsmol kg
-1
) and hyperosmolar (325 mOsmol kg
-1
) solution for 90-150 minutes. The mean 
CSA of cells (n=23) in hyperosmolar solution was not significantly different than cells (n=21) in 
isotonic solution. 
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After taking photographs, the cells either incubated in isotonic solution (n=21) or hyperosmolar 
solution (n=23) were patch clamped and the capacitance was measured after 90-150 minutes of 
incubation. There was a marked difference in the total cell capacitance between the two groups. 
Figure 4.4 shows that MNCs exposed to high osmolality had a mean capacitance significantly 
larger than that of the control MNCs (from 11.2 ± 0.5 pF to 15.0 ± 0.6 pF; P < 0.001 with an 
unpaired t-test), which represented a 34% increase for hyperosmolar versus control group. Our 
findings of an increase in cell capacitance from MNCs culture are similar in magnitude to the 
increase in cell capacitance observed in MNCs isolated from dehydrated rats by 33% with salt 
loading in their water for 7 days (Tanaka et al., 1999) and 25% with water deprivation for 16-24 
hours (Zhang et al., 2007a). This supports our hypothesis that MNCs hypertrophy is associated 
with an increase in total membrane surface area by the addition of new membrane through 
exocytotic fusion.         
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Figure 4.4 Cell capacitance of MNCs treated with normal and hyperosmolar solution. 
Whole cell patch clamp was performed on two groups of MNCs treated with control (295 
mOsmol kg
-1
) and hyperosmolar (325 mOsmol kg
-1
) solution for 90-150 minutes. The 
capacitance (pF) was recorded from each cell of both groups. The mean capacitance of 
cells (n=23) in hyperosmolality (15.0 ± 0.6 pF) was significantly higher then the 
capacitance of cells (n=21) in extracellular osmolality (11.2 ± 0.5 pF).  
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4.3 Prevention of hypertrophic response with TAT-NSF peptide 
To test whether the observed osmotically-evoked increase in CSA depends on exocytotic fusion 
of granules with the plasma membrane, I tested the response of cells to increases in osmolality in 
the presence of an agent (TAT-NSF700). TAT (human immunodeficiency virus transactivator of 
transcription) peptide (TAT-NSF700) that prevents SNARE-mediated exocytotic fusion by 
blocking the function of NSF (N-ethylmaleimide-sensitive factor) (Matsushita et al., 2005). 
Acutely isolated MNCs (n=67; from 15 preparations) were treated with hyperosmolar solution as 
described above in the presence of TAT-NSF700 peptide, while other MNCs (n=27; from 5 
preparations) were treated with scrambled version of the peptide (TAT-NSF700scr). The 
hypertrophy was observed by taking photographs at different intervals and the CSA (µm
2
) of 
cells was measured. It was observed that treated cells shrunk (349 ± 9 µm
2
 t=0 to 331± 8 µm
2
 
t=15 n = 67; P < 0.001 with a paired t-test) but showed no detectable hypertrophy (329± 8 µm
2
 
t=150; t=15 to t= 150 P > 0.05 with a paired t-test) (Figure 4.5). The hypertrophic response did 
not appear to be altered by the scrambled version of the peptide. The CSA first shrunk from 310 
± 14 µm
2
 to 292 ± 13 µm
2
 and then increased to 329 ± 15 µm
2 
(a 6% increase from t=0 to t= 150 
minute; n = 27; P < 0.001 with a paired t-test) as shown in Figure 4.5. Hypertrophy was 
however, virtually eliminated by preincubation with TAT-NSF700, suggesting that osmotically-
evoked hypertrophy depends on SNARE-mediated exocytotic fusion and hypertrophy is a result 
of insertion of new membrane.       
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   Figure 4.5 Effect of MNCs on hypertrophic response with TAT peptide and scrambled 
version of TAT peptide. The hypertrophic response was blocked by the preincubation of 
MNCs (n=67) with TAT peptide (TAT-NSF700) while the cells (n=27) treated with 
scrambled version of the peptide (TAT-NSF700scr) showed hypertrophy.  
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4.4 Immunocytochemistry of L-type Ca
2+
 channels following treatment with hyperosmolar                        
solution 
We performed immunocytochemistry to test for changes in expression of L-type Ca
2+ 
channels 
(Cav1.2 & Cav1.3) on the somata of VP-MNCs and OT-MNCs in response to increases in 
osmolality. Chronic dehydration causes increase in L-type Ca
2+
 channels density and L- type 
Ca
2+ 
currents (Zhang et al., 2007a). Both Cav1.2 and Cav1.3 are expressed in the somata and 
dendrites of MNCs (Joux et al., 2001) and mRNA for both channels are expressed in SON 
(Zhang et al., 2007a). Therefore both Cav1.2 and Cav1.3 may contribute to L-type Ca
2+
 channels 
in MNCs. We isolated MNCs acutely from 14 well hydrated rats and treated with either 
hyperotonic solution (325 mOsmol kg 
-1
) or isotonic solution (295 mOsmol kg 
-1
) for 2 hours. 
The difference in expression of L-type Ca
2+ 
channels in both groups of cells was observed by 
using antibodies against Cav1.2 and Cav1.3. We also labeled both groups with antibodies markers 
against OT and VP- MNCs (neurophysin I and II, respectively) to differentiate the 
immunoexpression of L-type Ca
2+
 channels in both types of MNCs). Immunoreactivity to NI & 
NII is represented by green fluorescence (Fig 4.6 and 4.7) and to L-type Ca
2+
 channels Cav1.2 & 
Cav1.3 is represented by red fluorescence (Fig 4.6 and 4.7). The immunofluorescence of Cav1.2 
and Cav1.3 showed intense and diffuse staining throughout the cell cytoplasm and plasma 
membrane suggesting a distribution of L-type Ca
2+
 channels in the cytoplasm and plasma 
membrane of the MNCs. It was found that MNCs treated with hyperosmolar solution had higher 
immunoreactivities for both Cav1.2 (Fig 4.8) and Cav1.3 (Fig 4.9). When plotted and analyzed, 
the mean intensities (intensity in arbitrary units per µm
2
) of Cav1.2 (Fig 4.10) and Cav1.3 (Fig 
4.11) was found significantly higher for the cells incubated for 2 hours with hypertonic solution 
compared to the cells treated with normal solution. The mean intensity of Cav1.2 was found to 
be; control=15 ±1 arbitrary units/µm
2
, hypertonic 30 ± 2 arbitrary units/µm
2
 P<0.001 with 
unpaired t test and Cav1.3; control = 13±1 arbitrary units/µm
2
, hypertonic 26 ±2 arbitrary 
units/µm
2
 P< 0.001 with unpaired t test. This suggests an increase in number of L-type Ca
2+
 
channels due to the increased synthesis of channel proteins during sustained hyperosmotic 
stimulation. These results do not rule out the other explanations for increase in L-type Ca
2+
 
channels i.e. it could be the translocation of channels from internal membranes of cytoplasm to 
surface of cells, which we could not observe because of the diffuse staining in the cytoplasm and 
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plasma membrane. Our results of increases in intensity of immunoreactivity to L-type Ca
2+
 
channels Cav1.2 & Cav1.3 in response to increased osmolality are consistent with radioligand 
binding results and whole cell patch clamp recordings in which the density of L-type Ca
2+
 
channels and total L-type Ca
2+
 currents, respectively were increased after dehydration (Zhang et 
al., 2007a). Six combinations were designed to see any difference between OT MNCs (NI) and 
VP- MNCs (NII) for the expression of L-type Ca
2+
 channels; Cav1.2 (Figure 4.10) and Cav1.3 
(Figure 4.11) but the difference was statistically not significant and VP-MNCs showed only a 
little higher intensity for expression of L-type Ca²
+
 channels as compared to OT-MNCs in 
normal and hypertonic solutions. We did not observe a significant change in intensity of 
immunostaining for NI and NII in control and hyperosmolar groups. The negative control 
showed no significant difference in immunoreactivity in hyperosmotically treated cells compared 
to control. This supports the hypothesis that hypertrophy observed in response to increased 
external osmolality is associated with the up-regulation of synthesis of L-type Ca
2+ 
channels 
(Cav1.2 & Cav1.3). 
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      A: DIC                            B:  NI&NII                    C: CaV1.2                       
Figure 4.6: Immunofluorescence in MNC using antibodies directed against its specific 
carrier proteins (NI and NII) and L-type Ca
2+
 channel: Cav1.2  Immunostaining 
results showing an MNC soma with one dendrite. A: A differential interference contrast 
(DIC) image of MNC, B: Green colour representing specific carrier protein targeted by 
using primary antibodies; Neurophysin I (NI) and Neurophysin II (NII), C: Red colour 
showing result of immunofluorescence by using primary antibody directed against L-type 
Ca
2+
 channel Cav1.2 to observe change in intensity of channels during hypertonic stimuli. 
Scale bar is 20 µm. 
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      A: DIC                            B:  NI&NII                      C: CaV1.3                     
 
Figure 4.7 Immunofluorescence in MNC using antibodies directed against its specific 
carrier proteins (NI and NII) and L-type Ca
2+
 channel: Cav1.3  Immunostaining 
results showing an MNC soma. A: differential interference contrast (DIC) image of 
MNC, B: Green colour representing specific carrier protein targeted by using primary 
antibodies; Neurophysin I (NI) and Neurophysin II (NII), C: Red colour showing result of 
immunofluorescence by using primary antibody directed against L-type Ca
2+
 channel 
Cav1.3 to observe change in intensity of channels during hypertonic stimuli. Scale bar is 
20 µm. 
 
 42 
 
         
 
                                                    
                       A: Control                                        B: Hyperosmolar 
Figure 4.8 The increase in immunofluorescence for Cav1.2 in acutely isolated MNCs due to 
increase in external osmolality Images are showing immunofluorescence towards 
Cav1.2 in MNCs acutely isolated from hydrated rats, treated with control (normal) and 
hyperosmolar (high osmolality) and cells were also identified as MNCs with specific 
carrier markers; NI and NII (not shown).  A: The MNC treated with control solution (295 
mOsmol kg
-1
) showing immunofluorescence for Cav1.2 and B: showing increased 
intensity of immunofluorescence for Cav1.2 after treatment of MNCs with hyperosmolar 
solution (325 mOsmol kg
-1
). The scale bar is 20 µm. 
 
 
 
 
 
 
 
A 
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                     A: Control                                        B: Hyperosmolar 
Figure 4.9 The increase in immunofluorescence for Cav1.3 in acutely isolated MNCs due to 
increase in external osmolality Images are showing immunofluorescence towards 
Cav1.3 in MNCs acutely isolated from hydrated rats, treated with control (normal) and 
hyperosmolar (high osmolality) and cells were also identified as MNCs with specific 
carrier markers; NI and NII (not shown). A: The MNC treated with control solution (295 
mOsmol kg
-1
) showing immunofluorescence for Cav1.3 and B: showing increased 
intensity of immunoflourescence for Cav1.3 after treatment of MNCs with hyperosmolar 
solution (325 mOsmol kg
-1
). The scale bar is 20 µm. 
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Figure 4.10 Immunofluorescence for L-type Ca
2+
 channel; Cav1.2 (A) MNCs 
immunoreactive to a mixture of antibodies directed against NI and NII showed higher 
mean intensity of immunofluorescence for Cav1.2 in the group of MNCs that were 
incubated with hyperosmolar solution. (B) OT-MNCs were identified by using their 
specific protein marker; NI and (C) VP-MNCs were identified by using their specific 
protein marker; NII to see the difference of L-type Ca
2+
 immunoexpression: Cav1.2 in 
both control and hypertrophied MNCs. The mean intensity of immunofluorescence was 
higher in cells in hyperosmolar solution in both types of cells (B&C) and there was no 
significant difference in expression of Cav1.2 between OT and VP-MNCs.  
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Figure 4.11 Immunofluorescence for Cav1.3 (A) MNCs immunoreactive to a mixture of 
antibodies directed against NI&NII showed higher mean intensity of 
immunofluorescence for Cav1.2 in MNCs treated with hyperosmolar solution. (B) OT-   
and (C) VP-MNCs were identified by using their specific protein marker; NI & NII, 
respectively. (B&C) The mean intensity of immunofluorescence was higher in cells in 
hyperosmolar solution in both types of cells OT & VP-MNCs and there was no 
significant difference in expression of Cav1.2 between both types of cells.                                             
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CHAPTER 5 
DISCUSSION 
 
During chronic dehydration, MNCs undergo hypertrophy, which is associated with increases in 
cell capacitance and L-type Ca
2+ 
current (Zhang et al., 2007a). This hypertrophy is opposite to 
the shrinkage of cells observed in MNCs culture in response to acute increases in osmolality 
(Zhang & Bourque, 2003). The mechanisms underlying the osmotically-induced hypertrophy of 
MNCs, which is likely to be a part of long term adaptation to increases in osmolality, is not clear. 
We therefore subjected MNCs in culture to hyperosmolar solutions for tens of minutes and 
observed a significant increase in the cell size (cross sectional area). Whole cell patch clamp 
recordings showed that osmotically-evoked hypertrophy is associated with an increase in cell 
capacitance of about 34%. This reflects the increase in total membrane surface area of MNCs 
and suggests insertion of new membrane into the cell surface. We observed the association of the 
hypertrophic increase in total membrane surface area with exocytotic fusion and also we 
observed the immunoexpression of L-type Ca
2+
 channels in normal and hypertrophied MNCs 
(Cav1.2 & Cav1.3). Our hypertrophy experiments and whole cell capacitance recordings 
confirmed that increases in external osmolality for 90-150 minutes cause an increase in the size 
of MNCs by increasing the total membrane surface area and that this increase is dependent on 
the exocytotic fusion of intracellular membrane with the plasma membrane. Our data from 
immunocytochemistry displayed a significant increase in expression of L-type Ca
2+
 channels 
(both Cav1.2 and Cav1.3) in MNCs treated with hyperosmolar solution as compared to control 
cells, suggesting increased synthesis of channels during sustained hyperosmotic stimulation. I 
will discuss first the difference between short term and long term changes in MNC size in 
response to increases in external osmolality.  
5.1 Short and long term osmotic changes 
Acute exposure to hyperosmolar and hypo-osmolar solutions rapidly causes shrinkage and 
swelling of cells, respectively with reversal to their original size upon removal of stimuli (Zhang 
& Bourque, 2003). In contrast, hippocampal cells compensate for osmotically-induced volume 
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changes (shrinking and swelling) because they exhibit volume regulatory compensatory 
mechanisms known as regulatory volume increase (RVI) and regulatory volume decrease 
(RVD).  RVI and RVD are the mechanisms to regulate the internal osmolality by the regulation 
of ion transport and accumulation of organic osmolytes to avoid the deleterious changes in cell 
volume due to changes in external osmolality (Lang, 2007). Due to the absence of compensatory 
mechanisms, osmotically-induced volume changes cause the greatest possible changes in the 
membrane tension which are indicators of external osmolality in MNCs.  Mechanosensitive 
channels (SICs) are activated in response to osmotically-evoked changes in cell volume and 
respond electrically to changes in membrane tension (Oliet & Bourque, 1993a). The plasma 
membrane of MNCs is depolarized when the hyperosmotic stimuli cause shrinkage of cell, 
release the membrane tension, activate SICs in a cytoskeleton-dependent manner and initiate the 
firing of MNCs for the release of hormone (Oliet & Bourque, 1993a; Oliet & Bourque, 1993b 
and Zhang et al., 2007b). MNCs do not show a change in total membrane surface area when they 
undergo acute shrinkage and swelling (Zhang & Bourque, 2003). Acute shrinkage and swelling 
of MNCs upon exposure to osmotic changes may be regulated by the folding and unfolding of 
membrane reserves and not the total membrane surface area (Zhang & Bourque, 2003).  This is 
how MNCs respond to acute hyperosmotic change but the scenario is different in long term 
hyperosmotic perturbations. 
Studies showed that the hypothalamo-neurohypophysial system (HNS) undergoes structural and 
functional plasticity during chronic dehydration, one aspect of which is hypertrophy of MNCs 
(Hatton, 1997; Zhang et al., 2007a). Similar changes were seen during lactation and parturition 
(Theodosis et al., 2004; Theodosis et al., 2008). Long term exposure to increases in osmolality 
causes an increase in MNC size and capacitance. Hypertrophy appears to be part of broader 
adaptation to high osmolality that enables sustained high level release of VP (Hatton, 1997). 
Different responses of MNCs to acute (Zhang & Bourque, 2003) and long term changes (Hatton, 
1997; Zhang et al., 2007a) in external osmolality led us to study osmotically-induced 
hypertrophy. The mechanism of this hypertrophy is unknown and difficult to study in vivo and 
we therefore attempted to study osmotically-induced hypertrophy in vitro.  
We observed hypertrophy in MNCs culture, treated with hyperosmolar solution over tens of 
minutes.  MNCs shrunk by about 10% of their original size as an acute response to hypersomolar 
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solution (325 mOsmol kg
-1
) after 15 minutes and this was observed by measuring the CSA of 
MNCs. The magnitude of shrinkage was consistent with acute shrinkage observed by Zhang & 
Bourque, 2003. We observed that cells gradually expanded in size after 15 minutes and attained 
a maximum size about 9% greater than their original size at 150 minutes. These data suggest that 
hypertrophy is a structural adaptation of MNCs in response to long term increases in external 
osmolality and may be required as part of structural plasticity for the facilitation of hormone 
release when there is need to regulate the change in external osmolality in MNCs.  
5.2 Hyperosmolality causes increase in total membrane surface area    
Chronic dehydration increases the capacitance of MNCs (Tanaka et al., 1999; Di & Tasker, 
2004; Zhang et al., 2007a). We therefore attempted to observe an association between 
osmotically-evoked hypertrophy with the increase in total cell capacitance in MNCs acutely 
isolated from normally hydrated rats. Whole cell patch clamp showed that MNCs treated with 
hyperosmolar solution (325 mOsmol kg
-1
) demonstrated a significant increase of 34% in 
capacitance as compared to control cells (295 mOsom kg
-1
). Our findings are consistent with the 
whole cell patch clamp results of capacitance taken from MNCs acutely isolated from rats either 
dehydrated for 16-24 hours by water deprivation or due to salt loading for 7-10 days which 
showed 20-33% increase in capacitance (Zhang et al., 2007a; Tanaka et al., 1999; Di & Tasker, 
2004). OT-MNCs displayed similar increases in capacitance during lactation (Teruyama & 
Armstrong, 2005). Total cell capacitance is not regulated by short term osmotic changes in 
MNCs (Zhang & Bourque, 2003). Cell capacitance directly reflects the total membrane surface 
area (Fernandez et al., 1984; Zhang & Bourque, 2003). This suggests that osmotically-evoked 
hypertrophy regulates the total membrane surface area as a result of exocytotic fusion of 
intracellular membrane with plasma membrane.  
We measured the cell CSA of MNCs before subjecting the cells to whole cell patch clamp. 
MNCs were identified on the basis of their CSA from non MNCs and we selected only cells 
which had CSA > 160µm² (Oliet & Bourque, 1992). The mean CSA of the hypertrophic group 
was slightly larger than the control group (10.5%), but this difference was not significant. This 
difference is similar to the results in Figure 4.1, but those results were significantly different 
because the data was paired. The data was not found significant also because of the large 
variation in cell size. For instance, we found the mean CSA of MNCs in control osmotic solution 
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was 276 µm² (n=21) with min and max values of 160 µm² and 390 µm² respectively while 
hyperosmolar group had mean CSA of 305 µm² (n=23) with min and max values of 196 µm² to 
493 µm², respectively.  
Our imaging experiments showed that MNCs increase in CSA (9% in Figure 4.1 and 10.5% in 
Figure 4.3) during two hours of incubation with high osmolality solutions. In order to see 
whether that treatment caused an increase in capacitance we tested other MNCs and treated them 
in same way. The capacitance of those cells was on average higher (34%) than control cells. This 
suggests that treatment of MNCs with high osmolality solutions for two hours caused an increase 
in CSA and also an increase in total membrane surface area. We can conclude from these results 
that increase in CSA is likely to be caused by insertion of new membrane in to plasma 
membrane. This raises the question of whether the size of the increase in CSA is appropriate for 
the increase in capacitance. The MNCs shrunk after exposure to increase in osmolality (t=15) as 
observed in hypertrophy experiments (Figure 4.1) by 10%. But over the next 135 minutes the 
increase in size was 21% (t=15 to t=150) (Figure 4.1) and this increase reflects the addition of 
new membrane.  
If the MNCs were perfect spheres and there was a 20% increase in CSA, then we would expect 
that there would be an 80% increase in capacitance. This is because the CSA would be equal to 
πr2 whereas the total membrane surface area would be equal to 4πr2.  So if CSA is 20% larger, 
the total membrane surface area would be increased by 4 times as much. This suggests that 34% 
increase in capacitance is smaller than we would expect for a 20% increase in CSA. The MNCs 
are not perfect spheres and as we have discussed it was not possible for us to get even a rough 
estimate of the true increase in membrane because of the odd shape of the MNCs, the presence of 
processes that may or may not increase in size and the presence of an unmeasureable amount of 
membrane reserves inside the cell that is invisible to us. Electron microscopy could be used to 
measure membrane reserves and total membrane surface area.  
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5.3 Hypertrophy is regulated by SNARE-mediated intracellular exocytotic fusion 
We tested whether the hyperosmotically-mediated increase in total membrane surface area of 
MNCs leading to hypertrophy is dependent on the SNARE-regulated exocytotic fusion of 
intracellular granules with the plasma membrane of cells or not. It was observed that MNCs did 
not undergo hypertrophy when pre-treated with cell membrane permeant TAT-NSF peptide in 
hyperosmolar solution. The TAT-NSF peptide blocks the SNARE complex of proteins that is 
responsible for SNARE mediated exocytotic fusion by interfering with the function of NSF 
(Matsushita et al., 2005). MNCs shrunk normally after 15 minutes but then did not show 
hypertrophy, whereas cells treated with the scrambled version of the peptide showed hypertrophy 
with 6% increase in cell CSA observed after 150 minutes. Therefore, our data confirms that 
increase in cell size (hypertrophy) is due to the insertion of new membrane into the cell surface. 
This data suggest that osmotically-evoked hypertrophy is regulated by an insertion of new 
membrane depending on the SNARE-mediated exocytotic fusion. The fusion of granules with 
plasma membrane could be a mechanism of translocation of receptors or channels for the 
sustained release of hormone during long term hyperosmolality. 
VP release from MNCs depends on the SNARE-mediated exocytotic fusion of large dense core 
granules (containing hormone) with the plasma membrane (Fisher & Bourque, 2001). Our data 
could not find whether the intracellular granules fusing with plasma membrane contain 
neuropeptide or not. VP is released when MNCs get signals to release for the reabsorption of 
water by acting on peripheral receptors in kidneys (Procino et al., 2008). Other than axons, VP is 
also released from somatodendritic regions of MNCs along with endogenous co-peptides, 
dynorphin and apelin. Somatodendritic release exerts autocrine feedback inhibition on VP output 
after binding with their receptors on MNCs (Brown et al., 2006) and it is a very slow process that 
takes from 2-5 hours to respond to osmotic changes (Gillard et al., 2007). MNCs adopt a phasic 
burst pattern of firing, which enhances for the sustained release of VP (Oliet & Bourque, 1993a; 
Oliet & Bourque, 1993b). It was observed during chronic hyperosmotic stimulation that 
dynorphin receptors (kappa-opioid receptors) are translocated to the MNCs plasma membrane 
(Shuster et al., 1999).  Dynorphin may also have a role in the modulation of phasic bursts 
(Brown & Bourque, 2004). This suggests that osmotically-evoked hypertrophy of MNCs more 
likely reflects the fusion of a distinct population of intracellular granules and that fusion may 
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result in translocation of receptors and channels to membrane surface of MNCs to regulate the 
cell firing for sustained hormone release. 
5.4 The activity dependence of osmotically-evoked hypertrophy  
Preliminary unpublished data suggest that osmotically-evoked hypertrophy of isolated MNCs is 
activity dependent. Hypertrophy can be reversed by blocking electrical activity (Na
+
 channels), 
SICs or Ca
2+
 influx through L-type Ca
2+ 
channels in hyperosmotically treated MNCs 
(unpublished data). It was observed in our lab that action potentials preventing by using Na
+  
channel blockers (TTX) in MNCs treated with hyperosmolar solution prevented hypertrophy. 
Pretreatment of cells with SB366791 (SIC channel blocker) and nifedipine (which blocks Ca
2+ 
influx through L-type Ca
2+ 
channels) also prevented hypertrophy (unpublished data). We 
observed increase in cell size and capacitances of MNCs in response to increase in external 
osmolality for tens of minutes suggesting increase in total membrane surface area, which is 
mediated by exocytotic fusion of intracellular granules with plasma membrane. Our findings and 
our lab results suggest that hypertrophy does not alter membrane tension or SIC activation itself 
and hypertrophic response may follow a sequence of events: hyperosmolality causes shrinkage of 
cells which activates the SICs leading to cell firing, increases in Ca
2+ 
influx through L-type Ca
2+ 
channels and the resultant increase in Ca
2+
 is necessary for the activation of hypertrophic 
response (unpublished data). This suggests that cells continue to fire following hypertrophy and 
this firing is necessary for the maintenance of MNCs hypertrophy and this response does not 
alter the activation of SICs by altering membrane tension. Exocytotic fusion may involve the 
granules containing neuropeptides and lead to the somatodendritic release of hormones or co-
peptides for the regulation of long term adaptation in response to osmotic stress. 
5.5 Sustained hyperosmolality causes increase in immunoexpression of L-type Ca
2+
 
channels  
Our immunocytochemistry results showed that hyperosmotically-evoked hypertrophy is 
associated with an increase in the total immunoreactivity to specific antibodies against L-type 
Ca
2+ 
channels including Cav1.2 and Cav1.3 in VP and OT-MNCs. Acutely isolated MNCs from 
normally hydrated rats were incubated either in normal osmolality solution or hyperosmolar 
solution for 2 hours. Our hypertrophy experiments showed that MNCs experience hypertrophy 
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after 150 minutes of treatment with hyperosmolar solution. We observed intensity of 
immunofluorescence in control and treated cells for Cav1.2 (15 ±1 arbitrary units/µm
2
, 30 ± 2 
arbitrary units/µm
2
) and Cav1.3 (13 ±1 arbitrary units/µm
2
, 26 ± 2 arbitrary units/ µm
2
) and 
found an overall increase in both types of channels in treated cells. Both Cav1.2 and Cav1.3 
contribute to L-type Ca
2+
 currents in neurons and have already been identified in MNCs through 
immunocytochemistry (Joux et al., 2001) and also through single cell RT-PCR (Glasgow et al., 
1999). L-type Ca
2+ 
channels; Cav1.2 and Cav1.3 are predominantly located on the somata and 
proximal dendrites of MNCs (Glasgow et al., 1999; Joux et al., 2001) and expression of voltage-
gated Ca
2+ 
channels on internal membranes was observed in the cytoplasmic pool of MNCs 
(Fisher et al., 2000). Our results are consistent with the increase in total L-type Ca
2+ 
currents 
observed through whole cell patch clamp recordings, which demonstrated 80% increase in total 
L-type Ca
2+
 currents in both with no change in other Ca
2+
 currents and an increase in L-type Ca
2+
 
channels binding sites observed through radio-ligand binding, which demonstrated 32% increase 
in L-type Ca
2+
channel density in acutely isolated MNCs from 16-24 hours of chronically 
dehydrated rats (Zhang et al., 2007a). Increases in osmolality do not cause any immediate 
change in total Ca
2+
 currents (Liu et al, 2005). Our data also showed a comparison of increased 
expression of these channels in VP and OT-MNCs and it was observed that there was no 
significant difference in expressions of VP (NII) and OT (NI) MNCs. Thus, our data from 
osmotically-induced increase in expression of L-type Ca
2+
 channels suggest that sustained 
increases in external osmolality causes increase in number of Ca
2+ 
channels in hypertrophied 
MNCs (VP & OT) by increasing synthesis of channel proteins. 
MNCs not only undergo a structural plasticity (hypertrophy) but also many other functional 
events including signal transduction, gene transcription and translation occur during this long 
term osmotic stress (Hatton, 1997).  The dramatic increase in immunoreactivity of L-type Ca
2+ 
channels (Cav1.2 and Cav1.3) in response to hyperosmotic treatment of MNCs for tens of 
minutes suggests that an increase in channel synthesis may be a part of this structural plasticity.  
In situ hybridization of MNCs acutely isolated from dehydrated rats demonstrated increase in 
Na
+ 
channel mRNA levels suggesting remodeling of electrogenic machinery of MNCs (Tanaka 
et al., 1999) and possibly new L-type Ca
2+
 channels are also synthesized during chronic osmotic 
stress. Whole cell patch clamp recordings showed increase in total L-type Ca
2+
 currents while 
RT-PCR to evaluate the increase in the synthesis of any type of Ca
2+ 
channels showed that there 
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was no increase in the mRNA coding for these channels in SON after water deprivation in rats 
(Zhang et al., 2007a) and these results were consistent with the microarray study that suggested 
no increase in mRNA level for any type of Ca
2+ 
channels following sustained increase in external 
osmolality (Hindmarch et al., 2006). Immunocytochemical study at electron microscopic level 
could find out the increase in synthesis of channels in hypertonic solution and protein synthesis 
inhibitors such as cycloheximide or emetine could also be used to block synthesis to confirm 
whether hyperosmotically-induced increases in L-type Ca
2+ 
channels (Cav1.2 & Cav1.3) 
immunoreactivity is due to increase in channel synthesis or not.  
We could not observe immunolabeling of L-type Ca
2+ 
channels selectively in cytoplasmic 
membranes in our results because of the diffuse staining through out the cytoplasm and plasma 
membrane so we could not find the translocation of channels on the basis of 
immunocytochemistry. We cannot rule out the translocation of existing L-type Ca
2+ 
channels 
from internal stores to the plasma membrane during sustained dehydration or long term 
incubation of MNCs in hyperosmolar solution. L-type Ca
2+ 
channels are expressed on the 
internal membranes of MNCs (Fisher et al., 2000) and dynorphin receptors are translocated from 
internal membrane to cell surface during sustained dehydration (Shuster et al., 1999). L-type 
Ca
2+ 
channels  are involved in the somatodendritic release of  dynorphin in hippocampal neurons, 
which suggests that L-type Ca
2+ 
channels may also be involved in the somatodendritic release of 
neuropeptides (VP/OT) and co-released peptides (e.g. dynorphin) during osmotically-evoked 
long term adaptation in MNCs. The translocation of channels could be detected by using 
fluorescently labeled dihydropyridines or receptor/channel binding ligands and by use of electron 
microscopy. 
5.6 Physiological consequences of hypertrophy and increase in L-type Ca
2+
 channels 
Chronic dehydration causes VP-MNCs to undergo hypertrophy, adopt phasic bursts (action 
potentials that last for tens of seconds with equal silent phases), increase in L-type Ca
2+ 
and Na
+
 
currents and their respective channels densities and increased expression of VP and dynorphin 
receptors (Bicknell, 1988; Zhang et al., 2007a; Tanaka et al., 1999). Structural changes occur 
selectively in OT-MNCs during lactation and parturition (Hussy, 2002). However, it was 
recently observed in our lab that osmotically-induced hypertrophy depends on the electrical 
activity (Na
+ 
channels) of MNCs and Ca
2+
 influx through L-type Ca
2+
 channels (unpublished 
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data). We observed that MNCs hypertrophy in response to hyperosmotic stimuli is associated 
with increases in total membrane surface area dependent on the exocytotic fusion of intracellular 
granule with plasma membrane. This suggests that hypertrophy may be involved in the 
regulation of structural and functional plasticity occurring in HNS for the sustained and high 
increase of hormone.  
L-types Ca
2+
 channels (Cav1.2 and Cav1.3) play significant roles including neuropeptide release, 
secretion and gene transcription in MNC somata and terminals (Fisher & Bourque, 1995; Fisher 
& Bourque, 1996; Fisher & Bourque, 2001; Foehring & Armstrong, 1996; Joux et al., 2001; 
Glasgow et al., 1999). L-type Ca
2+
 channels may be involved in the long term adaptation of 
MNCs as they play significant roles in gene transcription in neurons. They regulate CREB 
(cAMP response element binding) protein activation, which is a transcription factor controlled 
by the Ca
2+ 
influx through L-type Ca
2+ 
channels and NMDA receptors (Bading et al., 1993; 
Ginty et al., 1993; Komendantov et al., 2007). Phosphorylation and activation of CREB occurs 
because Ca
2+
 influx translocates the activated calmodulin to the nucleus (Deisseroth et al., 2003).  
L-type Ca
2+ 
channels play this role because of a sequence that enables them to interact with 
calmodulin and sequences in the C- termini of the Cav1.2 and Cav1.3 that enable them to interact 
with post synaptic adaptor proteins that anchor the channels at the specific location to initiate 
CREB activation (Dolmetsch et al., 2001, Weick et al., 2003; Zhang et al., 2006). Long term 
hyperosmotic stress regulate gene expression in MNCs through L-type Ca
2+
 channels (Cav1.2 & 
Cav1.3) (Burbach et al., 2001) and causes increase in expression of VP receptors (V1a) (Hurbin et 
al., 2002), Na
+ 
channels on the plasma membrane and increase in Na
+
 and L-type Ca
2+
 currents 
(Tanaka et al., 1999; Zhang et al., 2007a). This suggests that increase in L-type Ca
2+ 
channels 
could be important in the long term adaptation for enhancement of gene expression that occur in 
the development of hypertrophy for the sustained release of hormone. 
L-type Ca
2+ 
channels may be involved in the somatodendritic release of neuropeptides (VP/OT) 
and co-peptides (dynorphin & apelin) for the regulation of firing pattern in MNCs during 
sustained increase in external osmolality. Somatodendritic release have autocrine feed back 
control on the hormone release (Sladek, 2004; Ludwig & Leng, 2006) and can regulate synaptic 
inputs on MNCs (Ludwig et al., 2005) while dynorphin may regulate the phasic bursts in VP-
MNCs (Brown & Bourque, 2004). Phasic bursts are significant for the sustained release of VP 
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during chronic dehydration (Hatton, 1997). L-type Ca
2+ 
currents regulate dendritic release of 
dynorphin in hippocampal neurons (Simmons et al., 1995). The Ca
2+ 
dependent potentials such 
as DAP, HAP and AHP regulate firing rate and patterns in MNCs, which may be enhanced by 
the increase in L-type Ca
2+ 
currents/channels by depolarizing the plasma membrane due to Ca
2+ 
influx through these channels. Increase in L-type Ca
2+ 
channels may regulate the phasic bursts in 
MNCs by somatodendritic release of dynorphin for the sustained release of hormone and in 
maintenance of hypertrophy of MNCs during dehydration for the fluid homeostasis. 
L-type Ca
2+
 channels may regulate the exocytotic fusion of intracellular granule with the plasma 
membrane for the somatodendritic release of hormones in MNCs. VP/OT release is dependent on 
SNARE mediated exocytotic fusion (Fisher & Bourque, 2001) and synaptotagmin (a Ca
2+
sensor)  
which catalyzes this process (Gustavsson et al., 2009). We know that Cav1.2 and Cav1.3 have 
been found associated with the SNARE protein complex during different studies (Wiser et al., 
1999; Song et al., 2003). But there is lack of information on the association of synaptotagmin 
and L-type Ca
2+ 
channels in hypothalamic neurons (Gustavsson et al., 2009; Zhang et al., 2011). 
Exocytotic fusion of large dense core granules with the plasma membrane of chromaffin cells is 
mediated by Ca
2+ 
influx through L-type Ca
2+ 
channels where these channels enhance the 
neurotransmitter release by protein kinase C (PKC) translocation and MARKS phosphorylation 
(Park & Kim, 2009). Osmotically-evoked hypertrophy depends on the Ca
2+ 
influx through L-type 
Ca
2+
 channels (unpublished data) and exocytotic fusion of intracellular granules which suggests 
that increase in L-type Ca
2+
 channels during sustained increase in external osmoality may 
regulate the long term adaptation in MNCs.   
5.7 Significance of findings to osmotic regulation  
Structural and functional adaptations occur in HNS in response to long term osmotic changes and 
MNCs are sensitive to small changes in external osmolality (Bourque & Oliet, 1997). MNCs 
undergo hypertrophy as a function of long term external hyperosmolality (Hatton, 1997). We 
also demonstrated that hypertrophy causes increases in total cell capacitance that reflects an 
increase in total membrane surface area of MNCs and such finding may lead to further 
investigation of morphometrical changes in cells during sustained increase in osmolality. Our 
study indicates that osmotically-mediated hypertrophy in MNCs involves insertion of new 
membrane on the plasma membrane through SNARE mediated exocytotic fusion. Such finding 
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may contribute to identify the nature of fusing membrane and relationship of exocytotic SNARE 
proteins (synaptotagmins) with the hormone release in MNCs during sustained dehydration. Our 
results of hyperosmolality-evoked increase in immunoexpression of L-type Ca
2+ 
channels 
suggested the increase in synthesis of L-type Ca
2+ 
channels that may be significant in finding the 
role of L-type Ca
2+
 channels in long term adaptation of MNCs for hormone secretion and gene 
regulation during sustained osmotic stress. Therefore, our studies will be helpful in finding the 
physiology of MNCs in fluid homeostasis during long term dehydration and pathological 
conditions that cause increased plasma osmolality.  
5.8 Future directions  
Our findings will further lead to study and explore the mechanism of hypertrophy and 
biochemical or physical factors involved in osmotically-induced hypothalamic plasticity. The 
hypertrophy experiments will lead to use of fluorescence microscopy with membrane specific 
dyes to see the movements of membranes during hypertrophic response of MNCs to confirm 
whether hypertrophy depends on the exocytotic fusion of intracellular granules or due to 
inhibition of endocytosis. Our observations of increase in L-type Ca
2+
 channels during stimulated 
conditions will direct interest to see whether increase in the synthesis of channels can be 
prevented by blocking protein synthesis. Translocation of channels from the MNC cytoplasm to 
plasma membrane during increase in osmolality can be observed by using specific fluorescently 
labeled ligands of L-type Ca
2+
 channels. Identification of isoforms of synaptotagmin (Ca
2+
 
sensor) and syntaxin, which are important members of SNARE protein complex and their 
association with hypertrophic response and L-type Ca
2+ 
channels will also be an important step 
in exploring osmotically-induced plasticity. 
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                                           CHAPTER 6 
                                         CONCLUSION 
 
MNCs undergo hypertrophy as a result of increases in external osmolality lasting for tens of 
minutes. This hypertrophy involves an increase in the total membrane area of the MNCs, which 
suggests insertion of new membrane. The increase in surface area depends on the exocytotic 
fusion of intracellular vesicle membranes with the plasma membrane. Preliminary findings also 
suggest that osmotically-evoked hypertrophy is associated with an increase in the number of L-
type Ca
2+ 
channels in MNCs. The osmotically-evoked hypertrophy and increase in L-type Ca
2+ 
channels in MNCs may contribute to the structural and functional adaptation in response to 
chronic treatment of cells with hyperosmolar solution.  
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